<SEC-DOCUMENT>0001641172-25-015874.txt : 20250620
<SEC-HEADER>0001641172-25-015874.hdr.sgml : 20250620
<ACCEPTANCE-DATETIME>20250620170055
ACCESSION NUMBER:		0001641172-25-015874
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20250620
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250620
DATE AS OF CHANGE:		20250620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		251062162

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:CYCC="http://cyclacel.com/20250620">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_CYCC_cyclacel.com_20250620 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20250620_20250620 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001130166 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000005" name="dei:EntityCentralIndexKey">0001130166</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cycc-20250620.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-20</xbrli:startDate>
        <xbrli:endDate>2025-06-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-202025-06-20_custom_CommonStockParValue0.001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCC:CommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-20</xbrli:startDate>
        <xbrli:endDate>2025-06-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-202025-06-20_custom_PreferredStock0.001ParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCC:PreferredStock0.001ParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-20</xbrli:startDate>
        <xbrli:endDate>2025-06-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20250620__20250620_zzEIpU4Y1w5b"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_90C_edei--DocumentPeriodEndDate_c20250620__20250620_zMmiZVZJgMEa"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">June 20, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20250620__20250620_zZFXBk7XQ0ui"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000012" name="dei:EntityRegistrantName">CYCLACEL
PHARMACEUTICALS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20250620__20250620_zd7lcxwxGvua"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityFileNumber_c20250620__20250620_zcfKgDSyF56"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000014" name="dei:EntityFileNumber">0-50626</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20250620__20250620_zlUjDBbyhyQk"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000015" name="dei:EntityTaxIdentificationNumber">91-1707622</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction<br/>
    of incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission<br/>
    File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer<br/>
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20250620__20250620_zqfPRyh0sDZ4"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000016" name="dei:EntityAddressAddressLine1">Level
10, Tower 11, Avenue 5, The Horizon</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine2_c20250620__20250620_zOoDvucuEZC7"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000017" name="dei:EntityAddressAddressLine2">Bangsar
South City</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine3_c20250620__20250620_zCpQ8rdhnoci"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000018" name="dei:EntityAddressAddressLine3">No. 8, Jalan Kerinchi</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressPostalZipCode_c20250620__20250620_zmvFDeX3D9m9"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000019" name="dei:EntityAddressPostalZipCode">59200</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressCityOrTown_c20250620__20250620_zSn4eOzxqih8"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000020" name="dei:EntityAddressCityOrTown">Kuala Lumpur</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCountry_c20250620__20250620_zdAlhhrqY209"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt-sec:countrynameen" id="Fact000021" name="dei:EntityAddressCountry">Malaysia</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
Of Principal Executive Offices And Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_900_edei--CityAreaCode_c20250620__20250620_zwLC5Gxeesmf"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000022" name="dei:CityAreaCode">(908)</ix:nonNumeric></span> <span id="xdx_90F_edei--LocalPhoneNumber_c20250620__20250620_zho50Af1wzR"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000023" name="dei:LocalPhoneNumber">517-7330</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
Name or Former Address, if Changed Since Last Report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span id="xdx_906_edei--WrittenCommunications_c20250620__20250620_zHdZKr2kah5c"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000024" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.95pt; text-indent: -17.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span id="xdx_90C_edei--SolicitingMaterial_c20250620__20250620_zODuoCmIFeAi"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000025" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 17.95pt; text-indent: -17.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span id="xdx_903_edei--PreCommencementTenderOffer_c20250620__20250620_z9tBa472nCF9"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20250620__20250620_zW4xtQqCv7Fg"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000027" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section&#160;12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20250620__20250620__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zB9hMmiy0UAj"><ix:nonNumeric contextRef="From2025-06-202025-06-20_custom_CommonStockParValue0.001PerShareMember" id="Fact000028" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20250620__20250620__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zN4kYdbR6li2"><ix:nonNumeric contextRef="From2025-06-202025-06-20_custom_CommonStockParValue0.001PerShareMember" id="Fact000029" name="dei:TradingSymbol">CYCC</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span><span id="xdx_908_edei--SecurityExchangeName_c20250620__20250620__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001PerShareMember_zTom3OZ9pC9i"><ix:nonNumeric contextRef="From2025-06-202025-06-20_custom_CommonStockParValue0.001PerShareMember" format="ixt-sec:exchnameen" id="Fact000030" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span></span> Stock Market LLC</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20250620__20250620__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zfMJrMsghQC3"><ix:nonNumeric contextRef="From2025-06-202025-06-20_custom_PreferredStock0.001ParValueMember" id="Fact000031" name="dei:Security12bTitle">Preferred
    Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--TradingSymbol_c20250620__20250620__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zYmJBiFkWaSl"><ix:nonNumeric contextRef="From2025-06-202025-06-20_custom_PreferredStock0.001ParValueMember" id="Fact000032" name="dei:TradingSymbol">CYCCP</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span><span id="xdx_902_edei--SecurityExchangeName_c20250620__20250620__us-gaap--StatementClassOfStockAxis__custom--PreferredStock0.001ParValueMember_zrQaGua3LxXa"><ix:nonNumeric contextRef="From2025-06-202025-06-20_custom_PreferredStock0.001ParValueMember" format="ixt-sec:exchnameen" id="Fact000033" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20250620__20250620_zONPVzLff2Ll"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000034" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I<b>tem
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2025, Cyclacel Pharmaceuticals, Inc. (the &#8220;Company&#8221;) entered into a Securities Purchase Agreement (the &#8220;Purchase
Agreement&#8221;) with certain accredited investors (the &#8220;Investors&#8221;), pursuant to which the Investors agreed to purchase
from the Company an aggregate of 3,000,000 shares of Series F Convertible Preferred Stock (the &#8220;Series F Preferred Stock&#8221;)
of the Company at a purchase price of $1.00 per share for aggregate gross proceeds of $3,000,000, subject to the terms and conditions
of the Purchase Agreement. In connection with the transaction, the Company issued a series A common stock purchase warrant, series B
common stock purchase warrant and series C common stock purchase warrant to each Investor (collectively, the &#8220;Warrants&#8221;).
The proceeds of the transaction will be used for general corporate and operating purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investors agreed to invest a total of $3,000,000 at the closing of the transactions under the Purchase Agreement in exchange for an aggregate
of 3,000,000 shares of Series F Preferred Stock and 29,430,000 Warrants, which occurred on or about June 20, 2025 (the &#8220;Closing&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of Series F Preferred Stock is convertible into 3.27 shares of the Company&#8217;s common stock, par value $0.001 per share (&#8220;Common
Stock&#8221;). In no event will the Series F Preferred Stock be convertible into Common Stock in a manner that would result in each Investor
or their transferees or their affiliates holding more than the lower of (i) the maximum percentage of the number of shares of Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Series F
Preferred Stock that can be issued to the holder without requiring a vote of the stockholders of the Company under the rules and regulations
of The Nasdaq Capital Market (&#8220;Nasdaq&#8221;); and (ii) 4.99% of the number of shares of Common Stock outstanding immediately before
the original issue date (the &#8220;Series F Ownership Limitation&#8221;), prior to the date that the Company&#8217;s stockholders approve
the issuance of shares of Common Stock to the Investors upon conversion of the Series F Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
series A common stock purchase warrants entitle each Investor to purchase 3,270,000 shares of common stock of the Company at an exercise
price of $0.51 per share with an expiration date five years from the date of issuance. The series B common stock purchase warrants entitle
each Investor to purchase 3,270,000 shares of common stock of the Company at an exercise price of $0.60 per share with an expiration
date five years from the date of issuance. The series C common stock purchase warrants entitle each Investor to purchase 3,270,000 shares
of common stock of the Company at an exercise price of $0.68 per share with an expiration date five years from the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the Company filed a certificate of designations (the &#8220;Series F Certificate of Designations&#8221;) with
the Secretary of State of Delaware designating the rights, preferences and limitations of the shares of the Series F Preferred Stock
on June 20, 2025. The Series F Certificate of Designations provides, in particular, that the Series F Preferred Stock will vote together
with the Common Stock on an as-converted basis, subject to the Series F Ownership Limitation, subject further to adjustments for any
stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of Series F Preferred Stock will be entitled to participate in any dividends made on shares of Common Stock (on an as-converted
basis) if and when such dividends are declared. Upon any liquidation or sale of the Company or all or substantially all of its assets,
the holders of the Series F Preferred Stock will be entitled to receive pari passu with the other holders of preferred stock, prior to
and in preference to any distribution to holders of Common Stock, an amount equal to $1.00 per share, the stated value of the Series
F Preferred Stock, then held by them plus any accrued but unpaid dividends. Thereafter, the remaining assets of the Company will be distributed
to the holders of Common Stock until such holders receive a return of their capital originally contributed, and thereafter, any remaining
assets will be distributed to all holders of Common Stock and preferred stock pro rata based on the number of shares held on an as-converted
basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agreed to obtain approval by its stockholders, which will include, among other things, proposal for the issuance of all of the
Common Stock to the Investors in compliance with the rules and regulations of Nasdaq (without regard to any limitations on conversion
set forth in the Series F Certificate of Designations or exercise set forth in the Warrants).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the parties to the
Purchase Agreement and may be subject to limitations agreed upon by the contracting parties. Accordingly, the Purchase Agreement is incorporated
herein by reference only to provide information regarding the terms of the Purchase Agreement, and not to provide any other factual information
regarding the Company or its business, and should be read in conjunction with the disclosures in the Company&#8217;s periodic reports
and other filings with the Securities and Exchange Commission (the &#8220;Commission&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Purchase Agreement, the Warrants and the Series F Certificate of Designations do not purport to be
complete and are qualified in their entirety by reference to the full text of the Series F Certificate of Designations, the Purchase
Agreement and the Warrants which are filed as Exhibits 3.1, 10.1, 10.2, 10.3 and 10.4 respectively, to this Current Report on Form 8-K
and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02. Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disclosure required by this Item and included in Item 1.01 of this Current Report is incorporated herein by reference. The shares of
Series F Preferred Stock (and the shares of Common Stock issuable upon conversion thereof) and the Warrants (and the shares of Common
Stock issuable upon exercise thereof) are being sold without registration under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), in reliance on the exemption provided by Regulation S (&#8220;Regulation S&#8221;) of the Securities Act, which permits
offers or sales of securities by the Company outside of the United States that are not made to &#8220;U.S. Persons&#8221; or for the
account or benefit of a &#8220;U.S. Person&#8221;, as that term is defined in Rule 902 of Regulation S.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.03. Material Modifications to Rights of Security Holders.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disclosure required by this Item and included in Item 1.01 of this Current Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disclosure required by this Item and included in Item 1.01 of this Current Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2025, the Company issued a press release announcing the entry into the Purchase Agreement and Warrants and the Closing related
thereto. A copy of such press release is attached to this Current Report on Form 8-K as Exhibits 99.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forward-Looking
Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K contains certain forward-looking statements that involve risks and uncertainties that could cause actual results
to be materially different from historical results or from any future results expressed or implied by such forward-looking statements.
Such forward-looking statements include, among other things, statements related to the receipt of stockholder approval to issue the shares
of common stock pursuant to the contemplated transactions. You are urged to consider statements that include the words &#8220;may,&#8221;
&#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221;
&#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221;
&#8220;continues,&#8221; &#8220;forecast,&#8221; &#8220;designed,&#8221; &#8220;goal,&#8221; or the negative of those words or other
comparable words to be uncertain and forward-looking. These risks and uncertainties include the risk that the Company may not be successful
in receiving the stockholder approval contemplated, and the other risks described more fully in Cyclacel Pharmaceuticals&#8217; filings
with the Commission, including the &#8220;Risk Factors&#8221; section of the Company&#8217;s Annual Report on Form 10-K for the year
ending December 31, 2024 and its other documents subsequently filed with or furnished to the Commission, including its Form 10-Q for
the quarter ended March 31, 2025. For a further list and description of the risks and uncertainties the Company faces, please refer to
our most recent Annual Report on Form 10-K and other periodic filings we file with the Commission that are available at www.sec.gov.
Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking
statements, whether as a result of new information, future events or otherwise.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
    </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series F Preferred Stock</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form
    of Securities Purchase Agreement, dated as of June 20, 2025, by and among the Company and the Investors</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Form of Series A Common Stock Purchase Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-3.htm">Form of Series B Common Stock Purchase Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-4.htm">Form of Series C Common Stock Purchase Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release dated June 20, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    June 20, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cyclacel
    Pharmaceuticals, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top">By:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><i>/s/
    Datuk Dr. Doris Wong Sing Ee</i></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong Sing Ee</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Executive Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kd9qwjAUh5+g73Aou5SaFCbYO1ecjOkoKrLbrD1uwTannESnj7S3XJqu3c0WAiHJ7ztf/sTxJF7Ro66R4fVhu4Y9Nm2tHMIWj8hoSvSJ/Ok5Az9u8V1bx8q4MB3AnDyDnpklUvn1kLxoi1UGYjaV82l6D2KeyTksNnHU7edkjrpC47SqQZkKCqaWNTrFt77CXl3JUHMLpgOy1WQykInot78gFTKFF7qoT+KThfU6j6NJaFG8Yjq3PrW8OjQdCcsaG6+zPf3bw2nKs3XUZAV3d2asdo7Kk0iEkIXig6rPuMHmDdlHpUhTKRY/pxgJCMgE7gIFrWK4dNwfFv9aDZmQH6r3KuTdh+L/VD02eEbBaPT/YDt8MH4Dpq2K9Q== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CYCLACEL
PHARMACEUTICALS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATIONS, PREFERENCES,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
AND LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
F CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 151 OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DELAWARE
GENERAL CORPORATION LAW</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Datuk Dr. Doris Wong Sing Ee, does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
She is the Chief Executive Officer of Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<B>Corporation</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Corporation is authorized to issue 5,000,000 shares of preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The following resolutions were duly adopted by the board of directors of the Corporation (the &ldquo;<B>Board of Directors</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Amended and Restated Certificate of Incorporation of the Corporation, as amended, provides for a class of its authorized capital
stock known as preferred stock, consisting of 5,000,000 shares, $0.001 par value per share, issuable from time to time in one or more
series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Board of Directors is authorized to provide for the issuance of the shares of preferred stock in series and to establish, from time
to time, the number of shares to be included in each such series, and to fix the number, designation, powers, preferences and rights
of the shares of each such series and any qualifications, limitations or restrictions thereon; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and
other matters relating to a series of the preferred stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESOLVED</B>,
that the chief executive officer, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation
be and they hereby are authorized and directed to prepare and file this Certificate of Designations, Preferences, Rights and Limitations
in accordance with the foregoing resolution and the provisions of Delaware law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, BE IT FURTHER RESOLVED</B>, that the Board of Directors does hereby provide for the issuance of a series of preferred stock
to be designated the &ldquo;Series F Convertible Preferred Stock&rdquo; and does hereby fix and determine the number rights, preferences,
restrictions and other matters relating to such series of preferred stock as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
OF PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Beneficial
Ownership Limitation</B>&rdquo; shall have the meaning set forth in <B>Section 6(d)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
Day</B>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bylaws</B>&rdquo;
means the amended and restated bylaws of the Corporation, as they may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Certificate
of Designations</B>&rdquo; means this Certificate of Designations relating to the Series F Convertible Preferred Stock (the &ldquo;<B>Preferred
Stock</B>&rdquo;), as it may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Certificate
of Incorporation</B>&rdquo; shall mean the Amended and Restated Certificate of Incorporation of the Corporation, as it may be amended
from time to time, and shall include this Certificate of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Commission</B>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock</B>&rdquo; means the Corporation&rsquo;s common stock, par value $0.001 per share, and stock of any other class of securities into
which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock Equivalents</B>&rdquo; means any securities of the Corporation or its subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Conversion
Amount</B>&rdquo; means the sum of the Stated Value at issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Conversion
Date</B>&rdquo; shall have the meaning set forth in <B>Section 6(a)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Conversion
Shares</B>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Fundamental
Transaction</B>&rdquo; shall have the meaning set forth in <B>Section 7(d)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>GAAP</B>&rdquo;
means United States generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Holder</B>&rdquo;
shall have the meaning set forth in <B>Section 2</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Liquidation</B>&rdquo;
shall have the meaning set forth in <B>Section 5</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>New
York Courts</B>&rdquo; shall have the meaning set forth in <B>Section 8(d)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Notice
of Conversion</B>&rdquo; shall have the meaning set forth in <B>Section 6(a)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Original
Issue Date</B>&rdquo; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers
of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Preferred
Stock</B>&rdquo; shall have the meaning set forth in <B>Section 2</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Share
Delivery Date</B>&rdquo; shall have the meaning set forth in <B>Section 6(c)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Stated
Value</B>&rdquo; shall have the meaning set forth in <B>Section 2</B>, as the same may be increased pursuant to <B>Section 3</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Successor
Entity</B>&rdquo; shall have the meaning set forth in <B>Section 7(d)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the principal Trading Market is open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE MKT or the New York Stock
Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Transfer
Agent</B>&rdquo; means Equiniti Trust Company, LLC, and any successor transfer agent of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. <U>Designation, Amount and Par Value</U>. The series of preferred stock shall be designated as the Series F Convertible Preferred
Stock (the &ldquo;<B>Preferred Stock</B>&rdquo;) and the number of shares so designated shall be 3,000,000 (which shall not be subject
to change without the written consent of a majority of the holders of the Preferred Stock (each, a &ldquo;<B>Holder</B>&rdquo; and collectively,
the &ldquo;<B>Holders</B>&rdquo;)). Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value equal
to $1.00 (the &ldquo;<B>Stated Value</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. <U>Dividends</U>. Except for stock dividends or distributions for which adjustments are to be made pursuant to <B>Section 7</B>, Holders
shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis, without regard to conversion limitations herein) to and in the same form as dividends actually paid on shares of the Common Stock
when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of Preferred Stock.
The Corporation shall not pay any dividends on the Common Stock unless the Corporation simultaneously complies with this provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. <U>Voting Rights</U>. The Preferred Stock shall be counted (on an as-converted basis) for purposes of determining a quorum at a meeting
of stockholders and shall vote on matters of the Corporation on an as-if-converted-to-Common-Stock basis, subject to the provisions of
the Delaware General Corporation Law and subject to the Beneficial Ownership Limitation, and further subject to adjustments for any stock
splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the date hereof. Any vote or consent
of the stockholders may be taken either by vote at a meeting called for the purpose or by written consent without a meeting and in either
case may be given in person or by proxy. The rules and procedures for calling and conducting any meeting of the stockholders (including,
without limitation, the fixing of a record date in connection therewith), the solicitation and use of proxies at such a meeting, the
obtaining of written consents and any other aspect or matter with regard to such a meeting or such consents shall be governed by any
rules the Board of Directors or a duly authorized committee of the Board of Directors, in its discretion, may adopt from time to time,
which rules and procedures shall conform to the requirements of the Certificate of Incorporation, the Bylaws and applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. <U>Liquidation Preference.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary, subject to the
rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time
hereafter come into existence, the holders of the Preferred Stock shall be entitled to receive, prior and in preference to any
distribution of any of the assets of the Corporation to the holders of Common Stock by reason of their ownership thereof, the Stated
Value per share of Preferred Stock then held by them, plus declared but unpaid dividends. If, upon the occurrence of any
liquidation, dissolution or winding up of the Corporation, the assets and funds thus distributed among the holders of the Preferred
Stock shall be insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then, subject to the
rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time
hereafter come into existence, the entire assets and funds of the Corporation legally available for distribution shall be
distributed ratably among the holders of each series of preferred stock in proportion to the preferential amount each such holder is
otherwise entitled to receive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Upon the completion of the distribution required by <B>Section 5(a)</B> above and any other distribution that may be required with
respect to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from
time to time hereafter come into existence, if assets remain in the Corporation, the remaining assets shall be distributed to the
holders of the Common Stock until such time as the holders of the Common stock shall have received a return of the capital
originally contributed thereby. Thereafter, if assets remain in the Corporation, all remaining assets shall be distributed to all
holders of Common Stock and to each series of Preferred Stock, pro rata based on the number of shares of Common Stock held by each
(assuming conversion of all such Preferred Stock into Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
For purposes of this <B>Section 5</B>, a liquidation, dissolution or winding up of the Corporation shall be deemed to be occasioned
by, or to include, (i) the acquisition of the Corporation by another entity by means of any transaction or series of related
transactions (including, without limitation, any reorganization, merger or consolidation, but excluding any merger effected
exclusively for the purpose of changing the domicile of the Corporation); or (ii) a sale of all or substantially all of the assets
of the Corporation, unless the Corporation&rsquo;s stockholders of record as constituted immediately prior to such acquisition or
sale will, immediately after such acquisition or sale (by virtue of securities issued as consideration for the Corporation&rsquo;s
acquisition or sale or otherwise) hold at least fifty percent (50%) of the voting power of the surviving or acquiring entity in
approximately the same relative percentages after such acquisition or sale as before such acquisition or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
In any of the events specified in subsection (c) above, if the consideration received by the corporation is other than cash, its
value will be deemed its fair market value. Any securities shall be valued as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Securities not subject to restrictions on free marketability:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
If traded on a securities exchange, the value shall be deemed to be the average of the closing prices of the securities on such
exchange over the thirty-day period ending three (3) days prior to the closing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
If actively traded over-the-counter, the value shall be deemed to be the average of the closing bid or sale prices (whichever is
applicable) over the thirty-day period ending three (3) days prior to the closing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)
If there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Board of
Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The method of valuation of securities subject to restrictions on free marketability (other than restrictions arising solely by
virtue of a stockholder&rsquo;s status as an affiliate or former affiliate) shall be to make an appropriate discount from the market
value determined as above in (i) (A), (B) or (C) to reflect the approximate fair market value thereof, as mutually determined by the
Corporation and the holders of at least a majority of the voting power of all then outstanding shares of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
In the event the requirements of <B>Section 2(c)</B> are not complied with, the Corporation shall forthwith either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
cause such closing to be postponed until such time as the requirements of this <B>Section 5</B> have been complied with;
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
cancel such transaction, in which event the rights, preferences and privileges of the holders of the Preferred Stock shall revert to
and be the same as such rights, preferences and privileges existing immediately prior to the date of the first notice referred to in <B>Section
5(c)(iv)</B> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
The Corporation shall give each holder of record of Preferred Stock written notice of such impending transaction not later than
twenty (20) days prior to the stockholders&rsquo; meeting called to approve such transaction, or twenty (20) days prior to the
closing of such transaction, whichever is earlier, and shall also notify such holders in writing of the final approval of such
transaction. The first of such notices shall describe the material terms and conditions of the impending transaction and the
provisions of this <B>Section 5</B>, and the Corporation shall thereafter give such holders prompt notice of any material changes.
The transaction shall in no event take place sooner than twenty (20) days after the Corporation has given the first notice provided
for herein or sooner than ten (10) days after the corporation has given notice of any material changes provided for herein;
provided, however, that time periods set forth in this paragraph may be shortened upon the written consent of the holders of
Preferred Stock that are entitled to such notice rights or similar notice rights and that represent at least a majority of the
voting power of all then outstanding shares of such Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6. <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Conversions at Option of Holder</U>. Each one share of Preferred Stock shall be convertible, at any time and from time to time from
and after the Original Issue Date at the option of the Holder thereof, into three and twenty-seven hundredths (3.27) shares of Common
Stock (subject to the limitations set forth in <B>Section 6(c)</B>) (the &ldquo;<B>Conversion Ratio</B>&rdquo;). Holders shall effect
conversions by providing the Corporation with the form of conversion notice attached hereto as <B>Annex A</B> (a &ldquo;<B>Notice of
Conversion</B>&rdquo;). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of
shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion
at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers
by facsimile or email such Notice of Conversion to the Corporation (such date, the &ldquo;<B>Conversion Date</B>&rdquo;). If no Conversion
Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation
is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type
of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth in the Notice of Conversion
shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not
be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of
Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares
of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock in accordance
with the terms hereof shall be canceled and shall not be reissued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Mechanics of Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Conversion Shares Upon Conversion</U>. Not later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading
Days comprising the Standard Settlement Period (as defined below) after each Conversion Date (the &ldquo;<B>Share Delivery Date</B>&rdquo;),
the Corporation shall deliver, or cause to be delivered, to the converting Holder (A) the number of Conversion Shares being acquired
upon the conversion of the Preferred Stock and (B) a bank check in the amount of accrued and unpaid dividends, if any. As used herein,
&ldquo;<B>Standard Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Corporation&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Conversion. Notwithstanding
the foregoing, with respect to any Notice(s) of Conversion delivered by 12:00 pm (New York time) on the Original Issue Date, the Corporation
agrees to deliver the Conversion Shares subject to such notice(s) by 4:00 pm (New York time) on the Original Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Failure to Deliver Conversion Shares</U>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to
or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation
at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly
return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the
Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Obligation Absolute; Partial Liquidated Damages</U>. The Corporation&rsquo;s obligation to issue and deliver the Conversion Shares
upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or
inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against
any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder
or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such
Holder in connection with the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver
by the Corporation of any such action that the Corporation may have against such Holder. If the Corporation fails to deliver to a Holder
such Conversion Shares pursuant to <B>Section 6(b)(i)</B> by the Share Delivery Date applicable to such conversion, the Corporation shall
pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $1,000.00 of Stated Value of Preferred Stock being
converted, per Trading Day for each Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds
such conversion. Nothing herein shall limit a Holder&rsquo;s right to pursue actual damages for the Corporation&rsquo;s failure to deliver
Conversion Shares within the period specified herein, and such Holder shall have the right to pursue all remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such
rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</U>. In addition to any other rights available
to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery
Date pursuant to <B>Section 6(b)(i)</B>, and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase
(in an open market transaction or otherwise), or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating
to such Share Delivery Date (a &ldquo;<B>Buy-In</B>&rdquo;), then the Corporation shall (A) pay in cash to such Holder (in addition to
any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder&rsquo;s total purchase price
(including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares
of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which
the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of such
Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for
conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock
that would have been issued if the Corporation had timely complied with its delivery requirements under <B>Section 6(b)(i)</B>. For example,
if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage
commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the
Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts
payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein
shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver Conversion
Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>Reservation of Shares Issuable Upon Conversion</U>. Until no shares of Preferred Stock remain outstanding, the Corporation covenants
that, subject to any required stockholder approval in accordance with Delaware General Corporation Law, it will at all times reserve
and keep available out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the
Preferred Stock as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than
the Holder (and the other holders of the Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall
be issuable (taking into account the adjustments and restrictions of <B>Section 7</B>) upon the conversion of the then outstanding shares
of Preferred Stock. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized,
validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>RESERVED</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Transfer Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of the Preferred Stock shall be made without charge
to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares,
provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance
and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock
and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting
the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation
that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion
and all fees to the DTC (or another established clearing corporation performing similar functions) required for same-day electronic delivery
of the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Beneficial Ownership Limitation</U>. Notwithstanding anything to the contrary herein, the Corporation shall not effect any conversion
of the Preferred Stock, and a Holder shall not have the right to vote or convert any portion of the Preferred Stock, to the extent that,
after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder&rsquo;s
Affiliates, and any Persons acting as a group together with such Holder or any of such Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution
Parties</B>&rdquo;)) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below); provided, that, following
a vote of the stockholders of the Corporation in accordance with the rules and regulations of the Trading Market on which the Common
Stock trades on such date and applicable securities laws to approve the removal of the Beneficial Ownership Limitation, a Holder shall
have the right to convert any portion of the Preferred Stock, and the Corporation may effect any such conversion of the Preferred Stock.
For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates and
Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to
which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion
of the remaining, unconverted Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates or Attribution
Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation subject
to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred
Stock) beneficially owned by such Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence,
for purposes of this <B>Section 6(c)</B>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this <B>Section 6(c)</B> applies,
the determination of whether the Preferred Stock is convertible (in relation to other securities owned by such Holder together with any
Affiliates and Attribution Parties) and of how many shares of Preferred Stock are convertible shall be in the sole discretion of such
Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&rsquo;s determination of whether the shares of
Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties)
and how many shares of the Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance
with this restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such
conversion will not violate the restrictions set forth in this paragraph and the Corporation shall have no obligation to verify or confirm
the accuracy of such representation. In addition, a determination as to any group status as contemplated above shall be determined in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this <B>Section
6(c)</B>, in determining the number of outstanding shares of Common Stock, a Holder may rely solely on the number of outstanding shares
of Common Stock as stated in a written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock
outstanding. Upon the written or oral request (which may be via email) of a Holder, the Corporation shall within two Trading Days confirm
orally and in writing to such Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares
of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the
Preferred Stock, by such Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall mean, as of any date, the lower of (X) the
maximum percentage of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock issuable upon conversion of the Preferred Stock that can be issued to the Holder without requiring a vote of the stockholders
of the Corporation under the rules and regulations of the Trading Market on which the Common Stock trades on such date and applicable
securities laws; and, (Y) 4.99% of the number of shares of the Common Stock outstanding immediately before the Original Issue Date. The
provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this
<B>Section 6(c)</B> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial
Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a successor holder of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Stock Splits</U>. If the Corporation, at any time while this Preferred Stock is outstanding: (i) pays a stock
dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other
Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon
conversion of, or payment of a dividend on, this Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number
of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares,
or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then
the number of shares of Common Stock each share of Preferred Stock shall be convertible into shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately
before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event.
Any adjustment made pursuant to this <B>Section 7(a)</B> shall become effective immediately after the record date for the determination
of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in
the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <B>Section 7(a)</B> above, if at any time the Corporation
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to
the record holders of any class of shares of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if
the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&rsquo;s Preferred Stock (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Preferred Stock is outstanding, if the Corporation declares or makes any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;),
at any time after the issuance of this Preferred Stock, then, in each such case, the Holder shall be entitled to participate in such
Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common
Stock acquirable upon complete conversion of this Preferred Stock (without regard to any limitations on conversion hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (provided, however, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result
in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution
to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the
portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would
not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while any shares of Preferred Stock are outstanding, (i) the Corporation, directly or
indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii)
the Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all
or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted
to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property, or (v) the Corporation, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent conversion of the Preferred Stock by the Holder thereof, the
Holder shall receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence
of such Fundamental Transaction (without regard to any limitation in <B>Section 6(d)</B> on the conversion of the Preferred Stock), the
number of shares of common stock (as applicable) of the successor or acquiring corporation or the number of shares of Common Stock of
the Corporation (as applicable), if it is the surviving corporation, and all additional securities (equity or debt), cash, property or
other consideration (all such additional consideration, the &ldquo;<B>Alternate Consideration</B>&rdquo;), receivable as a result of
such Fundamental Transaction by a holder of the number of shares of Common Stock for which such Holder&rsquo;s Preferred Stock is convertible
immediately prior to such Fundamental Transaction (without regard to any limitation in <B>Section 6(d)</B> on the conversion of the Preferred
Stock). If holders of Common Stock are entitled to elect the proportion of securities, cash, property or other consideration to be received
by holders of Common Stock in a Fundamental Transaction, then each Holder of Preferred Stock shall be given the same choice as to the
proportion of securities, cash, property or other consideration such Holder is entitled to receive upon any conversion of such Holder&rsquo;s
shares of Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any
successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designations in respect
of a new series of preferred stock of the successor or acquiring corporation, or the Corporation, if it is the surviving corporation,
setting forth the same rights, preferences, privileges and other terms contained in this Certificate of Designations in respect of the
Preferred Stock, including, without limitation, the provisions contained in this <B>Section 7(d)</B> and evidencing, among other things,
the Holders&rsquo; right to convert such new preferred stock into Alternate Consideration. The Corporation shall cause any successor
entity in a Fundamental Transaction in which the Corporation is not the survivor (the &ldquo;<B>Successor Entity</B>&rdquo;) to assume
in writing all of the obligations of the Corporation under this Certificate of Designations in accordance with the provisions of this
<B>Section 7(d)</B> pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of a Holder of Preferred Stock, deliver to
such Holder in exchange for such Holder&rsquo;s Preferred Stock a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to the Preferred Stock which is convertible for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion
of the Preferred Stock (without regard to any limitations on the conversion of the Preferred Stock) prior to such Fundamental Transaction,
and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Preferred
Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
to the Holder(s) thereof. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designations referring to
the &ldquo;Corporation&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation
and shall assume all of the obligations of the Corporation under this Certificate of Designations with the same effect as if such Successor
Entity had been named as the Corporation herein. For the avoidance of doubt, if, at any time while any shares of Preferred Stock are
outstanding, a Fundamental Transaction occurs, pursuant to the terms of this <B>Section 7(d)</B>, a Holder of Preferred Stock shall not
be entitled to receive any consideration in such Fundamental Transaction in respect of such Holder&rsquo;s shares of Preferred Stock,
except as provided for in this Certificate of Designations (or any new Certificate of Designations in respect of a new series of preferred
stock issued to the Holders of Preferred Stock as contemplated hereby).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Intentionally Omitted. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to the Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Conversion Amount</U>. Whenever the number of shares of Common Stock that the shares of Preferred Stock are convertible
into is adjusted pursuant to any provision of this <B>Section 7</B>, the Corporation shall promptly deliver to each Holder a notice setting
forth the number of shares of Common Stock after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Conversion by Holder</U>. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)
the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any
shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer
of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property or (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency
maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered to each Holder at its last address
as it shall appear upon the stock books of the Corporation, at least fifteen (15) calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information
regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part
hereof) during the 15-day period commencing on the date of such notice through the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, email address or sent by a nationally
recognized overnight courier service, addressed to the Corporation at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cyclacel
Pharmaceuticals, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
10, Tower 11, Ave. 5, No. 8 Jalan Kerinchi</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bangsar
South, Wilayah Persekutuan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuala
Lumpur, Malaysia, 59200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>info@cyclacel.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to (which shall not constitute notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debbie
Klis, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rimon
Law, P.C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1050
Connecticut Ave NW, Suite 500<BR>
Washington D.C. 20036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
<U>debbie.klis@rimonlaw.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
such other facsimile number or address (physical or email) as the Corporation may specify for such purposes by notice to the Holders
delivered in accordance with this <B>Section 8</B>. Any and all notices or other communications or deliveries to be provided by the Corporation
hereunder shall be in writing and delivered personally, by facsimile, by email attachment or sent by a nationally recognized overnight
courier service addressed to each Holder at the facsimile number, email address or address of such Holder appearing on the books of the
Corporation, or if no such facsimile number, email address or address appears on the books of the Corporation, at the principal place
of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the time of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number
or email address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date
of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address
set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the
second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual
receipt by the Person to whom such notice is required to be given. Notwithstanding any other provision of this Certificate of Designations,
where this Certificate of Designations provides for notice of any event to a Holder, if the Preferred Stock is held in global form by
DTC (or any successor depositary), such notice may be delivered via DTC (or such successor depositary) pursuant to the procedures of
DTC (or such successor depositary).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Absolute Obligation</U>. Except as expressly provided herein, no provision of this Certificate of Designations shall alter or impair
the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable,
on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Lost or Mutilated Preferred Stock Certificate</U>. If a Holder&rsquo;s Preferred Stock certificate shall be mutilated, lost, stolen
or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate,
or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so
mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of
the ownership hereof reasonably satisfactory to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designations
shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the
principles of conflict of laws thereof. Each of the Corporation and each Holder agrees that all legal proceedings concerning the interpretation,
enforcement and defense of the transactions contemplated by this Certificate of Designations (whether brought against the Corporation,
a Holder or any of their respective Affiliates, directors, officers, stockholders, employees or agents) shall be commenced in the state
and federal courts sitting in the City of Wilmington, Delaware (the &ldquo;<B>Delaware Courts</B>&rdquo;). Each of the Corporation and
each Holder hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Delaware Courts,
or such Delaware Courts are improper or inconvenient venue for such proceeding. Each of the Corporation and each Holder hereby irrevocably
waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such Person at the address in effect for notices
to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by applicable law. Each of the Corporation and each Holder hereby irrevocably waives, to the fullest extent permitted by applicable law,
any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designations or the transactions
contemplated hereby. If the Corporation or any Holder shall commence an action or proceeding to enforce any provisions of this Certificate
of Designations, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&rsquo;
fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Waiver</U>. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designations shall not operate
as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of
Designations or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term
of this Certificate of Designations on one or more occasions shall not be considered a waiver or deprive that Person (or any other Holder)
of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designations on any other
occasion. Any waiver by the Corporation or a Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Severability</U>. If any provision of this Certificate of Designations is invalid, illegal or unenforceable, the balance of this Certificate
of Designations shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain
applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder
violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designations
and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Status of Converted Preferred Stock</U>. If any shares of Preferred Stock shall be converted or reacquired by the Corporation, such
shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series F Convertible
Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the undersigned have executed this Certificate this ___ day of _______ 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CYCLACEL
    PHARMACEUTICALS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong Sing Ee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer of the Corporation</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert shares of Series F Convertible Preferred Stock (the &ldquo;Preferred Stock&rdquo;), into shares
of common stock (&ldquo;Common Stock&rdquo;) of Cyclacel Pharmaceuticals, Inc. according to the terms and conditions of the Certificate
of Designation of Preferences, Rights and Limitations of Series F Convertible Preferred Stock (the &ldquo;Certificate of Designation&rdquo;),
as of the date written below. Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in
the Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Conversion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Shares of Preferred Stock to be Converted:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Shares of Preferred Stock Owned Prior to Conversion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Shares of Preferred Stock Owned After Conversion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>Signature:
___________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
10.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF SECURITIES PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of __________, 2025 (the &ldquo;Effective Date&rdquo;),
between Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and _______, an individual (the &ldquo;<U>Purchaser</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to the applicable regulations under the U.S. Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), the Company desires to issue and sell to the Purchaser, and the
Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
it is also understood by the parties that the Company is entering into this Agreement in order to provide for the issuance and sale by
the Company of the Securities (as defined below) in an &ldquo;offshore transaction&rdquo; within the meaning of Regulation S under the
Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Certificate of Designations (as defined herein), and (b) the following terms have
the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning given such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning given such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company or any authorized committee thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday, any day which is a federal legal holiday in the United States or any other
day on which commercial banks in The City of New York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>,
for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including
for wire transfers) of commercial banks in The City of New York are generally open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Certificate
of Designations</U>&rdquo; means the Certificate of Designations of the Series F Preferred Stock to be filed prior to the Closing by
the Company with the Secretary of State of Delaware, in the form of <U>Exhibit A</U>, attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
has the meaning set forth in Section 2.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means, with respect to each Closing, the Trading Day on which all of the Transaction Documents with respect to the applicable
Closing, have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchaser&rsquo;s
obligations to pay the Purchase Price and (ii) the Company&rsquo;s obligations to deliver the Securities, have been satisfied or waived,
but in no event later than the second (2<SUP>nd</SUP>) Trading Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Party</U>&rdquo; means all directors, officers, stockholders, employees, agents, and representatives, including those directors comprising
of the current board of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning given such term in the Certificates of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof and thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading
Day, no later than 9:01 a.m. (New York City time) on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning given such term in Section 3.1(r).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; shall have the meaning given such term in the recitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning given such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning given such term in Section 3.1(z).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means an adverse claim, lien, charge, pledge, security interest, encumbrance, right of first refusal, or preemptive right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning given such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Maximum
Rate</U>&rdquo; shall have the meaning given such term in Section 5.16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; means the number of shares of the Company&rsquo;s Series F Convertible Preferred Stock issued as set forth in the Certificate
of Designations, having the rights, preferences and privileges therein, in the form set forth in <U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or, to the Company&rsquo;s knowledge, threatened in writing, against the Company before or by
any court, arbitrator, governmental, or administrative agency or regulatory authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus to be filed in accordance with the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser</U>&rdquo;
shall have the meaning set forth in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning given to such term in Section 4.11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Price</U>&rdquo; means One Million dollars (U.S.$1,000,000), payable in accordance with the terms herein in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning given such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Minimum</U>&rdquo; means, as of any date, the maximum aggregate number of shares of Common Stock issuable or potentially issuable in
the future pursuant to the Transaction Documents, including through the conversion of the Preferred Stock and exercise of the Warrants,
ignoring any conversion and limits set forth in the Certificate of Designations and Warrants, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning given such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Preferred Stock, the Conversion Shares, the Warrants and the Warrants Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; shall have the meaning given such term in the recitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A Warrants</U>&rdquo; means a warrant to purchase up to 3,270,000 shares of Common Stock at an exercise price of $0.51 in substantially
the form attached hereto as <U>Exhibit C-1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
B Warrants</U>&rdquo; means a warrant to purchase up to 3,270,000 shares of Common Stock at an exercise price of $0.60 in substantially
the form attached hereto as <U>Exhibit C-2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
C Warrants</U>&rdquo; means a warrant to purchase up to 3,270,000 shares of Common Stock at an exercise price of $0.68 in substantially
the form attached hereto as <U>Exhibit C-3</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the OTC (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Certificate of Designations, all exhibits and schedules thereto and hereto,
and any other documents or agreements executed by all or any of the Parties hereto in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means EQ Shareowner Services (Equiniti), the current transfer agent of the Company, with a mailing address of 6201 15th
Avenue, Brooklyn, NY 11219, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined as follows: (a) the weighted average daily volume weighted average price of the Common Stock
for the five (5) Trading Days immediately preceding such date (or the nearest preceding date) on the Trading Market on which the Common
Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m.
(New York City time)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means the Series A Warrants, Series B Warrants and Series C Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Purchase of Preferred Stock and Warrants</U>. Upon the terms and subject to the conditions set forth herein, the Company agrees to
sell, and the Purchaser agrees to purchase One Million United States Dollars (U.S.$1,000,000) worth of shares of Series F Preferred Stock,
at a price per share of $1.00, or One Million (1,000,000) shares of Series F Preferred Stock, and the Warrants. Each share of Series
F Preferred Stock shall be convertible into three and twenty-seven hundredths (3.27) shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Closing</U>. The Closing shall take place as set forth below (the &ldquo;<U>Closing</U>&rdquo;). On the Closing Date, upon the terms
and subject to the conditions set forth herein, the Purchaser shall transfer $1,000,000 in the manner set forth in Section 2.4(b)(i),
and the Company shall deliver to the Purchaser 1,000,000 shares of Series F Preferred Stock and the Warrants, and the Company and the
Purchaser shall deliver the other items set forth in Section 2.3 that are deliverable at the Closing. Upon satisfaction of the covenants
and conditions set forth in Section 2.4, the Closing shall take place remotely by electronic transfer of the Closing deliverables and
documentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
Deliverables.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to the Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
a book-entry statement or share certificate evidencing issuance of the Series F Preferred Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Warrants;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.5pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
an as-filed Certificate of Designations for the Series F Preferred Stock, in the form attached hereto as <U>Exhibit A</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.5pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
a copy of resolutions of the Company&rsquo;s Board of Directors authorizing Company&rsquo;s execution, delivery, and performance of this
Agreement, including, <I>inter alia</I>, the authorization and issuance of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.5pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the applicable Closing Date, the Purchaser shall deliver or cause to be delivered to the Company, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Purchase Price by wire transfer to the account as specified in writing by the Company in <U>Exhibit B</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
Closing Conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on each Closing Date of the representations and warranties of the Purchaser contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Purchaser of the items set forth in Section 2.3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The obligations of the Purchaser hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on each Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall have
been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.3 (a);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s Trading Market, and, at any time prior
to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum
prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a
banking moratorium have been declared by the United States authorities nor shall there have occurred after the date of this Agreement
any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or
any material adverse change in, any financial market which, in each case, in the reasonable judgment of the Purchaser, makes it impracticable
or inadvisable to purchase any of the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the SEC Reports and the Disclosure Schedules, which Disclosure
Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure
contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties
to the Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect Subsidiaries of the Company, if any, and their respective jurisdictions of incorporation
or organization are set forth in the SEC Reports. Other than as stated in the SEC Reports, the Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and, all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and, other than as set forth in the SEC Reports, each of the Subsidiaries is an entity
duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation
or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently
conducted. Other than as set forth in the SEC Reports, neither the Company nor any Subsidiary is in violation nor default of any of the
provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the
Company, and other than as set forth in the SEC Reports, any Subsidiaries is duly qualified to conduct business and is in good standing
as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes
such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not result in:
(i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect
on the results of operations, assets, business, liabilities or condition (financial or otherwise) of the Company and any Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;); provided,
that a change in the market price or trading volume of the Common Stock alone shall not be deemed to constitute a Material Adverse Effect;
and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party
has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof,
will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to receipt of the Required Approvals,
conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any
court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. Except as set forth in SEC Reports, the Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents,
other than: (i) the filings and approvals required pursuant to Sections 4.7, 4.12 and 4.14, (ii) the notice and/or application(s) to
each applicable Trading Market for the issuance and sale of the Securities and the listing of the Conversion Shares for trading thereon
in the time and manner required thereby, and (iii) such filings as are required to be made under applicable state securities laws (collectively,
the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Preferred Stock is duly designated (as applicable), authorized and, when issued and paid for in
accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid, and nonassessable, free and clear
of any Lien imposed by the Company. The Conversion Shares, upon issuance, will be duly and validly issued, fully paid, and nonassessable,
free and clear of any Lien imposed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule
3.1(g)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. Except as set forth on <U>Schedule 3.1(g)</U> no Person has any right of first refusal, preemptive right, right of
participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth
on Schedule 3.1(g) and as a result of the purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into
or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Common Stock or other securities,
or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional
Common Stock or Common Stock Equivalents. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to
issue Common Stock or other securities of the Company to any Person (other than the Purchaser). Except as set forth in the SEC Reports,
there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price under any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any
share appreciation rights or &ldquo;phantom share&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance
in all material respects with all federal and state securities laws where applicable, and none of such outstanding shares was issued
in violation of any preemptive rights or similar rights to subscribe for or purchase securities. Except for the Required Approvals, no
further approval or authorization of any stockholder of the Company, the Board of Directors of the Company or others is required for
the issuance and sale of the Securities. There are no stockholder agreements, voting agreements or other similar agreements with respect
to the Company&rsquo;s share capital to which the Company is a party or, to the knowledge of the Company, between or among any of the
Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material
respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the
Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest financial statements included
within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U> or except as disclosed in the SEC Reports, (i) there has been no
event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company
has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary
course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements
pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting in any
material respect, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders
or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued
any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does
not have pending, before the Commission, any request for confidential treatment of information. Except for the issuance of the Securities
contemplated by this Agreement, or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development
has occurred or exists or is reasonably expected to occur or exist with respect to the Company or any Subsidiary, or their respective
businesses, prospects, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under
applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one Trading
Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, Proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company or any of their respective
properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county,
local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely
affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if
there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any
Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability
under federal or state securities laws or a claim of breach of fiduciary duty that could result in a Material Adverse Effect. Except
as set forth on <U>Schedule 3.1(j)</U>, there has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or executive officer of the Company. The
Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company
or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. Except as set forth on <U>Schedule 3.1(k)</U>, no labor dispute exists or, to the knowledge of the Company, is
imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect.
None of the Company&rsquo;s employees is a member of a union that relates to such employee&rsquo;s relationship with the Company, and
the Company is not a party to a collective bargaining agreement, and the Company believes that its relationships with its employees are
good. To the knowledge of the Company, no executive officer of the Company, is, or is now expected to be, in violation of any material
term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any
other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive
officer does not subject the Company to any liability with respect to any of the foregoing matters. The Company is in compliance with
all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions
of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Except as set forth on <U>Schedule 3.1(l)</U> of the Company Disclosure Schedules, the Company: (i) is not in default
under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result
in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in
default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it
is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is not in
violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has, to the Company&rsquo;s
knowledge, not been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. To the knowledge of the Company, the Company (i) are in compliance with all federal, state, local and foreign
laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land
surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous
Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company possesses all certificates, authorizations and permits issued by the appropriate federal, state,
local or foreign regulatory authorities necessary to conduct its business as currently conducted, except where the failure to possess
such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and the
Company has not received any notice of Proceedings relating to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company has good and marketable title in fee simple to all real property owned by it and good and marketable
title in all personal property owned by them that is material to the business of the Company, in each case free and clear of all Liens,
except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed
to be made of such property by the Company and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves
have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property
and facilities currently held under lease by the Company are held by them under valid, subsisting and enforceable leases with which the
Company are in compliance in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Offering Exemption</U>. Subject to the accuracy of the representations of the Purchaser set forth in this Agreement, the offer, sale
and issuance of the Securities to be issued in conformity with the terms of this Agreement constitute transactions which are exempt from
the registration requirements of the Securities Act and from all applicable state registration or qualification requirements. The Company
has implemented all necessary offering restrictions applicable to the transactions contemplated by this Agreement under Regulation S
promulgated under the Securities Act. Subject to the receipt of the Required Approvals and assuming the accuracy of the Purchaser&rsquo;s
representations and warranties set forth in Section 3.2, the issuance and sale of the Securities hereunder will not contravene the rules
and regulations of the Trading Market. Assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in Section
3.2, the issuance and sale of the Securities by the Company to the Purchaser is exempt from the Prospectus requirements of applicable
securities laws of the location of the Purchaser and no Prospectus or other document is required to be filed, under such applicable securities
laws and no Proceeding is required to be taken and no approval, permit, consent or authorization of regulatory authorities is required
to be obtained by the Company under such securities laws to permit such issuance and sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Transactions With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company
and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company (other
than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending
of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements
under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries, if any, are in compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules
and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date, except
in each case as disclosed in the Company&rsquo;s SEC Reports. The Company maintains a system of internal accounting controls sufficient
to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. The Company has established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) for the Company and designed such disclosure controls and procedures to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the
time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness
of the disclosure controls and procedures of the Company as of the end of the period covered by the most recently filed periodic report
under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic
report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures
based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over
financial reporting (as such term is defined in the Exchange Act) of the Company that have materially affected or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Certain Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents. The Purchaser shall have no obligation with respect to any fees or with respect to any claims made by or
on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated
by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, required to register as an &ldquo;investment company&rdquo; within the meaning of the Investment Company
Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not be required to register as an &ldquo;investment
company&rdquo; subject to registration under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Registration Rights</U>. Except as set forth in the SEC Reports, no Person has any right to cause the Company or any Subsidiary to
effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to the Company&rsquo;s knowledge is likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating
terminating such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof,
received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market. The Company has taken commercially reasonable efforts
to reach compliance with the listing or maintenance requirements in the foreseeable future. The Common Stock is currently eligible for
electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment
of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchaser as a result of the Purchaser&rsquo;s and the Company&rsquo;s
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchaser&rsquo;s ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided the Purchaser or its agents or counsel with
any information that it believes constitutes or might constitute material, non-public information which has not been otherwise disclosed.
The Company understands and confirms that the Purchaser will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchaser regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including in the SEC Reports or the Disclosure Schedules to this
Agreement, is true and correct, in all material respects, and does not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made,
not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as
a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading.
The Company acknowledges and agrees that the Purchaser neither makes nor has made any representations or warranties with respect to the
transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) any applicable stockholder approval provisions of any Trading
Market on which any of the securities of the Company are listed or designated, or (ii) the Securities Act which would require the registration
of any such securities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Solvency</U>. Based on the financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, the fair saleable value of the Company&rsquo;s assets (including the proceeds
from the sale of Securities hereunder) exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing
known debts and other liabilities (including known contingent liabilities) as they mature as of the Closing Date. The Company does not
intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable
on or in respect of its debt). For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed
money or amounts owed in excess of fifty thousand U.S. dollars ($50,000) (other than trade accounts payable incurred in the ordinary
course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether
or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z)
the present value of any lease payments in excess of fifty thousand U.S. dollars ($50,000) due under leases required to be capitalized
in accordance with GAAP. Except as set forth in the SEC Reports, the Company is not in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, if any, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Accountants and Lawyers</U>. The Company&rsquo;s independent accounting firm was RSM US LLP. To the knowledge and belief of the Company,
such accounting firm: (i) was a registered public accounting firm as required by the Exchange Act and (ii) expressed its opinion with
respect to the financial statements that were included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ending December
31, 2023. The Company&rsquo;s current independent accounting firm is Bush &amp; Associates CPA LLP. There are no disagreements of any
kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly
or presently employed by the Company and the Company is current with respect to any fees owed to its accountants and lawyers which could
affect the Company&rsquo;s ability to perform any of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Acknowledgment Regarding Purchaser&rsquo;s Purchase of Securities</U>. The Company acknowledges and agrees that the Purchaser is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that the Purchaser is not acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by the
Purchaser or any of the Purchaser&rsquo;s representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchaser&rsquo;s purchase of the Securities. The Company further represents to the
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>No General Solicitation or Directed Selling Efforts</U>. Neither the Company nor any Person acting on behalf of the Company has offered
or sold any of the Securities by any form of general solicitation or general advertising or &ldquo;directed selling efforts&rdquo; (as
defined in Rule 902(c) of Regulation S). The Company has offered the Securities for sale only to the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s equity incentive plans was granted (i)
in accordance with the terms of the Company&rsquo;s equity incentive plans and (ii) with an exercise price at least equal to the fair
market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option
granted under the Company&rsquo;s equity incentive plans has been backdated. The Company has not knowingly granted, and there is no and
has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock
options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial
results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Cybersecurity</U>. To the knowledge and belief of the Company, (i)(x) there has been no security breach or other compromise of or
relating to any of the Company&rsquo;s material information technology and computer systems, networks, hardware, software, data (including
the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of the Company),
equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company has not been notified in writing
of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise
to its IT Systems and Data; (ii) the Company is presently in compliance in all material respects with all applicable laws or statutes
and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies
and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and
Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material
Adverse Effect; (iii) the Company has implemented and maintained commercially reasonable safeguards to maintain and protect its material
confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company
has implemented backup and disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>U.S. Real Property Holding Corporation</U>. The Company is not or has never been a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Affiliates is subject to the Bank Holding Company Act of 1956, as
amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Affiliates owns or controls, directly or indirectly, five percent (5%) or more
of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Affiliates exercises a controlling
influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither
the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in
all material respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting
Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchaser</U>. The Purchaser hereby represents and warrants as of the date hereof and as of
the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. The Purchaser has the right and legal capacity to enter into and to consummate the transactions contemplated
by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. Each Transaction Document to which
it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in accordance with the terms hereof or thereof,
will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. The Purchaser is acquiring the Securities in compliance with applicable securities laws, and in
the ordinary course of its business. The Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not
been registered under the Securities Act or any applicable state securities law, has no present intention of distributing any of such
Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such
the Purchaser&rsquo;s right to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal
and state securities laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time the Purchaser was offered the Securities, it was, and as of the date hereof it is, it will be either
(i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act, or
(ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities Act. In addition, if the Purchaser
has purchased the Securities pursuant to Regulation S, and the Purchaser represents and warrants that (i) at the time he, she or it was
offered the Securities he, she or it was not, as of the date hereof it is not, and throughout the Closing Date he, she or it will continue
not to be, a &ldquo;U.S. Person&rdquo; as that term is defined in Rule 902 of Regulation S, and (ii) he, she or it has, and will at all
times have, executed all documents (including this Agreement) outside of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>General Solicitation</U>. The Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or, to the knowledge of the Purchaser, any other general solicitation or general advertising. In addition, the
Purchaser is not purchasing the Securities as a result of any &ldquo;directed selling efforts&rdquo; (as defined in Rule 902(c) of Regulation
S) in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Experience of Purchaser</U>. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Access to Information</U>. The Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, the Purchaser has not
directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with the Purchaser, executed any purchases
or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that the Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Other than to other Persons party to
this Agreement, or to such Purchaser&rsquo;s and/or transferee&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser and/or transferee has maintained the
confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).
Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or
preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Restrictive Legends</U>. The Purchaser agrees that the Preferred Stock and the Conversion Shares, issued pursuant to exemptions from
registration under the Securities Act, shall each bear legends stating that transfer of those Securities is restricted, substantially
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY ARE BEING OFFERED TO INVESTORS WHO ARE NOT U.S. PERSONS (AS DEFINED
IN REGULATION S UNDER THE SECURITIES ACT OF 1933, AS AMENDED (&ldquo;THE SECURITIES ACT&rdquo;)) AND WITHOUT REGISTRATION WITH THE UNITED
STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT IN RELIANCE UPON REGULATION S PROMULGATED UNDER THE SECURITIES ACT.
TRANSFER OF THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY IS PROHIBITED, EXCEPT PURSUANT TO REGISTRATION
UNDER THE SECURITIES ACT OR PURSUANT TO AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE
WITH THE SECURITIES ACT. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo;
AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. Subject to compliance with the terms of this
Agreement, the Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its
obligation to issue the Conversion Shares pursuant to the Transaction Documents when required in accordance with their terms, are unconditional
and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution
or any claim the Company may have against the Purchaser or any transferee thereof, and regardless of the dilutive effect that such issuance
may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Furnishing of Information; Public Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports
required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the
reporting requirements of the Exchange Act, except in the event that the Company consummates (in each case on or after the date as of
which the Purchasers may sell all of their Securities without restriction or limitation pursuant to Rule 144): (a) any transaction or
series of related transactions as a result of which any Person (together with its Affiliates) acquires then outstanding securities of
the Company representing more than fifty percent (50%) of the voting control of the Company; (b) a merger or reorganization of the Company
with one or more other entities in which the Company is not the surviving entity; or (c) a sale of all or substantially all of the assets
of the Company, where the consummation of such transaction results in the Company no longer being subject to the reporting requirements
of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At any time commencing the date hereof and ending at such time that all of the Securities may be sold without the requirement for the
Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company
(i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer
described in Rule 144 (i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth in
Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s other available remedies,
the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or
reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%) of the Purchase Price on the day of a
Public Information Failure and on every thirtieth (30<SUP>th</SUP>) day (prorated for periods totaling less than thirty days) thereafter
until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer
required for the Purchaser to transfer the Conversion Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled
pursuant to this Section 4.3(b) are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo; Public Information
Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure
Payments are incurred and (ii) the third (3<SUP>rd</SUP>) Business Day after the event or failure giving rise to the Public Information
Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public
Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing
herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall
have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction
unless stockholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Conversion Procedures</U>. The Purchaser agrees not to convert any of the Preferred Stock until the Required Approvals are obtained.
The form of Notice of Conversion included in the Certificate of Designations sets forth the totality of the procedures required of the
Purchaser in order to convert the Preferred Stock into shares of Common Stock. Without limiting the preceding sentences, no ink-original
Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice
of Conversion form be required in order to convert the Preferred Stock. No additional information or instructions shall be required of
the Purchaser or transferee thereof to convert the Preferred Stock. The Company shall honor the conversions of the Preferred Stock and
shall deliver Conversion Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Bankruptcy</U>. The Company shall not voluntarily initiate, or cause to be initiated, any bankruptcy proceeding for itself, unless
required by applicable law. Notwithstanding the above, the Company may initiate such proceedings for any or all of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. In addition, effective upon the issuance of such press release,
the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral,
between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees, Affiliates or agents,
and the Purchaser or any transferee thereof, shall terminate and be of no further force or effect. The Company understands and confirms
that Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and Purchaser
shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the
Company nor the Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of
the Company, with respect to any press release of the Purchaser , or without the prior consent of the Purchaser , with respect to any
press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law,
in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of the Purchaser, or include the name of the Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of the Purchaser, except:
(a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to
the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchaser with
prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with the Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Stockholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that the Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that the Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Preferred Stock hereunder in its sole discretion
not in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Indemnification of the Company</U>. Subject to the subsections of this Section 4.10, the Purchaser will indemnify and hold the Company
and each Company Party harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses,
including all judgments, amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that
any such Company Party may suffer or incur as a result of or relating to (a) any inaccuracy in or breach of any of the representations,
warranties, covenants or agreements made by the Purchaser in this Agreement or in the other Transaction Documents or (b) any action instituted
against the Company in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company, with respect to
any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such
Company Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such
Company Party may have with any such stockholder or any violations by such Company Party of state or federal securities laws or any conduct
by such Company Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action
shall be brought against any Company Party in respect of which indemnity may be sought pursuant to this Agreement, such Company Party
shall promptly notify the Purchaser in writing, and the Purchaser shall have the right to assume the defense thereof with counsel of
its own choosing reasonably acceptable to the Company Party. Any Company Party shall have the right to employ separate counsel in any
such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Company
Party except to the extent that (i) the employment thereof has been specifically authorized by the Purchaser in writing, (ii) the Purchaser
has failed within ten days after notice from the Company Party to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Purchaser and the position
of such Company Party, in which case the Purchaser shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Purchaser will not be liable to any Company Party under this Agreement (y) for any settlement by a Company Party
effected without the Purchaser&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Company Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Company Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.10 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Company Party against the Purchaser or others and any liabilities the Purchaser may be subject to pursuant to
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Indemnification of Purchaser</U>. Subject to the subsections of this Section 4.11, the Company will indemnify and hold the Purchaser
and its directors, officers, stockholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), (each, a &ldquo;<U>Purchaser Party</U>&rdquo;)
harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party
may suffer or incur as a result of or relating to (a) any inaccuracy in or breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser
Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of
such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely
based upon a material breach of such Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents
or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party
of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud,
gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in respect of which indemnity may
be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the
right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party
shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed within twenty (20) days after notice from the Purchaser Party to assume
such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any
material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible
for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party
under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall
not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable
to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.11 shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The
indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the
Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Reservation and Listing of Securities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except to the extent limited by the Company&rsquo;s authorized shares of Common Stock, the Company shall maintain a reserve from its
duly authorized shares of Common Stock for issuance pursuant to the Transaction Documents in such amount as may then be required to fulfill
its obligations in full under the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum
on such date, then the Board of Directors shall include a proposal for an amendment to the Company&rsquo;s certificate of incorporation
to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum at a duly called meeting of
the stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company shall, if applicable: (i) in the time and manner required by the principal Trading Market, prepare and file with such Trading
Market an additional shares listing application covering a number of shares of Common Stock at least equal to the Required Minimum on
the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be listed on such Trading Market
as soon as possible thereafter, (iii) provide to the Purchaser evidence of such listing and (iv) use commercially reasonable efforts
to maintain the listing of such Common Stock on such Trading Market. The Company agrees to maintain the eligibility of the Common Stock
for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation,
by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic
transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Certain Transactions and Confidentiality</U>. The Purchaser covenants that neither it, nor any Affiliate acting on its behalf or pursuant
to any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company&rsquo;s securities during
the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.7. The Purchaser covenants that until such
time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as
described in Section 4.7, the Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information
included in this Agreement and the Disclosure Schedules (other than as disclosed to its legal and other representatives). Notwithstanding
the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees
that (i) the Purchaser makes no representation, warranty or covenant hereby that it will not engage in effecting transactions in any
securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.7; (ii) the Purchaser shall not be restricted or prohibited from effecting any transactions
in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.7; and (iii) the Purchaser
shall have no duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, Affiliates or agents after the issuance of the initial press release as described
in Section 4.7. Notwithstanding the foregoing, if the Purchaser is a multi-managed investment vehicle whereby separate portfolio managers
manage separate portions of the Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of the Purchaser&rsquo;s assets, the covenant set forth above shall only apply
with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered
by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Stockholder Approval</U>. The Company agrees to obtain approval of the stockholders of the Company for the transactions contemplated
by this Agreement, including the removal of any beneficial ownership limits of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
5.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Fees and Expenses</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company agrees to pay all costs and expenses incident to the performance of its obligations under this Agreement, whether or not
the transactions contemplated hereunder are consummated or this Agreement is terminated, including expenses, fees and taxes in connection
with (i) the preparation, issuance and delivery of the certificates for the Securities to the Purchaser, including any stock or other
transfer taxes or duties payable upon the sale of the Securities to the Purchaser, (ii) the filing for any required review of the offering
of the Securities by FINRA (including the legal fees and filing fees and other disbursements of counsel for the Purchaser relating thereto),
(iii) the fees and expenses incurred in connection with the listing of the Conversion Shares on Nasdaq, and (iv) the performance of the
Company&rsquo;s other obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except as expressly set forth in the Transaction Documents to the contrary, including, <I>inter alia</I>, each Party shall otherwise
pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such Party
incident to the negotiation, preparation, execution, delivery and performance of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction
letter delivered by the Company and any conversion notice delivered by the Purchaser), stamp taxes and other taxes and duties levied
in connection with the delivery of any Securities to the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise
of any such right. Any amendment effected in accordance with this Section 5.4 shall be binding upon the Purchaser and holder of Securities
and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of the Purchaser (other than by merger). The Purchaser may assign any or all of its rights under this Agreement to any Person to whom
the Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred
Securities, by the provisions of the Transaction Documents that apply to the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced or waived by, any other Person, except
as otherwise set forth in Section 5.6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.10, the prevailing party in such Action or Proceeding
shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for
the period of the applicable statute of limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file or other electronic signing crated on an electronic platform (such as DocuSign), such signature
shall be deemed to have been duly and validly delivered and shall create a valid and binding obligation of the party executing (or on
whose behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever the Purchaser exercises a right, election, demand or option under a Transaction
Document, and the Company does not timely perform its related obligations within the periods therein provided, then the Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary
damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents
and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at
law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to the Purchaser pursuant to any Transaction Document
or the Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Usury</U>. To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever
claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at
any time hereafter in force, in connection with any Action or Proceeding that may be brought by the Purchaser in order to enforce any
right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document,
it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature
of interest shall not exceed the maximum lawful rate authorized under applicable law (the &ldquo;<U>Maximum Rate</U>&rdquo;), and, without
limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums
in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed
that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by
statute or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will
be the Maximum Rate applicable to the Transaction Documents from the Closing Date thereof forward, unless such application is precluded
by applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to the Purchaser
with respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by the Purchaser to the unpaid principal
balance of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at the Purchaser&rsquo;s election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken, or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<B><U>WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Pages Follow]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cyclacel
    Pharmaceuticals, Inc. </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
                                            for Notice:</U></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 5%"></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 43%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cyclacel
                                            Pharmaceuticals, Inc.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            10, Tower 11, Avenue 5, No. 8</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
                                            Dr. Doris Wong Sing Ee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jalan
                                            Kerinchi,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuala
                                            Lumpur, Malaysia 59200</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
                                            Datuk Dr. Doris Wong Sing Ee, CEO</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
                                            info@cyclacel.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
                                            a copy to (which shall not constitute notice):</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debbie
                                            Klis, Esq.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rimon
                                            Law, P.C.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1050
                                            Connecticut Ave NW, Suite 500<BR>
                                            Washington D.C. 20036</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
                                            <U>deborrah.klis@rimonlaw.com</U></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASER
SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASER:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name<FONT STYLE="font-variant: small-caps">:_________________</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
                                            for Notice:</U></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>E-Mail</U>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
F PREFERRED STOCK CERTIFICATE OF DESIGNATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 33; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Exhibit A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WIRE
INSTRUCTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
name:.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
name:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Swift
Code:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wire
Routing #:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACH
Routing #:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
#:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
payments should be remitted in USD only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Send
remittance to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Exhibit B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
C-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
A COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 35; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Exhibit C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
C-2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
B COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
C-3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
C COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DISCLOSURE
SCHEDULES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 38; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
    C-1</B></FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
A COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
PHARMACEUTICALS, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 3,270,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: June 20, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: June 20, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES A COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on June 20, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Cyclacel
Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 3,270,000 shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 20, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>0.51, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) delivered pursuant to Section
    2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
    NMS promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of the Common Stock on the principal
    Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) within two (2) hours of the time of the Holder&rsquo;s
    delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular
    trading hours,&rdquo; or within two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or (iii) the
    VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
    Exercise is delivered pursuant to Section 2(a) hereof after two (2) hours following the close of &ldquo;regular trading hours&rdquo;
    on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;the
    Exercise Price of this Warrant, as adjusted hereunder; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics of
Exercise</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading
Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Holder&rsquo;s
    Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
    any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
    as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons
    acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
    would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence,
    the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the
    number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but
    shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion
    of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
    of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common
    Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned
    by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this
    Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
    promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
    is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed
    in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this
    Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
    and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice
    of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities
    owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in
    each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy
    of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance
    with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in
    determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock
    as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
    a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting
    forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one
    Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number
    of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
    Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of
    outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall mean, as of any date,
    the lower of (X) the maximum percentage of the number of shares of Common Stock outstanding immediately after giving effect to the
    issuance of shares of Common Stock issuable upon exercise of this Warrant that can be issued to the Holder without requiring a vote
    of the stockholders of the Company under the rules and regulations of the Trading Market on which the Common Stock trades on such
    date and applicable securities laws; and (Y) 4.99% of the number of shares of Common Stock outstanding immediately after giving effect
    to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase
    or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
    in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
    of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue
    to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice
    is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict
    conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
    with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
    give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If
    the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owed
    to the Holder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a
party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the
Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be
determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to
become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or
in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent
that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of
the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.
The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective
date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
                                            PHARMACEUTICALS, inc.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CYCLACEL PHARMACEUTICALS, inc. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
    B</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:______________________<U></U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:______________________<U></U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>ex10-3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.3 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
C-2 </B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
B COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
PHARMACEUTICALS, inc.</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares: 3,270,000</FONT></TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="text-align: right; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: June 20, 2025</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
Date: June 20, 2025</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES B COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on June 20, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Cyclacel
Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 3,270,000 shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 20, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>0.60, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="width: 0.15in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: center; width: 0.15in">=</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) delivered pursuant to Section 2(a) hereof on a Trading
Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal
securities laws) on such Trading Day, (ii) the highest Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) within two (2) hours of the time of the Holder&rsquo;s delivery of the Notice of Exercise pursuant
to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular trading hours,&rdquo; or within two (2) hours after
the close of &ldquo;regular trading hours&rdquo; on a Trading Day or (iii) the VWAP on the date of the applicable Notice of Exercise
if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is delivered pursuant to Section 2(a) hereof after
two (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="width: 0.15in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: center; width: 0.15in">=</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Exercise
Price of this Warrant, as adjusted hereunder; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="width: 0.15in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD><TD STYLE="text-align: center; width: 0.15in">=</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of
Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading
Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall mean, as of any date, the lower of (X) the maximum percentage of the number of shares of Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant that can be issued to the Holder without
requiring a vote of the stockholders of the Company under the rules and regulations of the Trading Market on which the Common Stock trades
on such date and applicable securities laws; and (Y) 4.99% of the number of shares of Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may
increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of
shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.
Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered
to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable
as a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owed to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><I>&nbsp;</I></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)<BR STYLE="clear: both">
</I></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL PHARMACEUTICALS, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B></B></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk Dr. Doris Wong</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CYCLACEL
PHARMACEUTICALS, inc.</FONT></TD>
</TR></TABLE>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&#8239;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8239;
] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%; text-align: right">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 35%"></TD><TD STYLE="text-align: justify; width: 45%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: right; width: 20%">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 35%"></TD><TD STYLE="text-align: justify; width: 45%">&nbsp;</TD>
</TR>
</TABLE>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: right; width: 20%">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 35%"></TD><TD STYLE="text-align: justify; width: 45%">&nbsp;</TD>
</TR>
</TABLE>


<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: right; width: 20%">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 35%"></TD><TD STYLE="text-align: justify; width: 45%">&nbsp;</TD>
</TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD>
    <TD STYLE="width: 8%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
                                            Print)</FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Phone
Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email
    Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:____________________________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:_____________________________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>6
<FILENAME>ex10-4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
    C-3</B></FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
C COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
PHARMACEUTICALS, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 3,270,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: June 20, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: June 20, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES C COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on June 20, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Cyclacel
Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 3,270,000 shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 20, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>0.68, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) delivered pursuant to Section
    2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
    NMS promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of the Common Stock on the principal
    Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) within two (2) hours of the time of the Holder&rsquo;s
    delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular
    trading hours,&rdquo; or within two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or (iii) the
    VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
    Exercise is delivered pursuant to Section 2(a) hereof after two (2) hours following the close of &ldquo;regular trading hours&rdquo;
    on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;the
    Exercise Price of this Warrant, as adjusted hereunder; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
    of Exercise</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading
Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Holder&rsquo;s
    Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
    any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
    as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons
    acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
    would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence,
    the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the
    number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but
    shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion
    of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
    of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common
    Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned
    by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this
    Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
    promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
    is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed
    in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this
    Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
    and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice
    of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities
    owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in
    each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy
    of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance
    with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in
    determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock
    as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
    a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting
    forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one
    Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number
    of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
    Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of
    outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall mean, as of any date,
    the lower of (X) the maximum percentage of the number of shares of Common Stock outstanding immediately after giving effect to the
    issuance of shares of Common Stock issuable upon exercise of this Warrant that can be issued to the Holder without requiring a vote
    of the stockholders of the Company under the rules and regulations of the Trading Market on which the Common Stock trades on such
    date and applicable securities laws; and (Y) 4.99% of the number of shares of Common Stock outstanding immediately after giving effect
    to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase
    or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
    in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
    of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue
    to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice
    is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict
    conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
    with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
    give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If
    the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owed
    to the Holder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCLACEL
    PHARMACEUTICALS, inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
CYCLACEL PHARMACEUTICALS, inc. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
    B</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:_______________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CYCLACEL
PHARMACEUTICALS ANNOUNCES $3 MILLION PRIVATE<BR>
PLACEMENT OFFERING OF CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KUALA
LUMPUR, June 20, 2025 </B>&ndash; Cyclacel Pharmaceuticals, Inc. (&ldquo;Cyclacel&rdquo;) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical
company that develops innovative cancer medicine, today announced that it has entered into a securities purchase agreement for the sale
of its convertible Series F Preferred Stock (&ldquo;Preferred Stock&rdquo;) in a private placement to certain accredited investors yielding
gross proceeds of $3.0 million before deducting offering expenses. In connection with the offering, Cyclacel issued to each investor,
a series A common stock purchase warrant to purchase 3,270,000 shares of the Company&rsquo;s common stock, par value $0.001 per share
(&ldquo;Common Stock&rdquo;) at an exercise price of $0.51 per share, series B common stock purchase warrant to purchase 3,270,000 shares
of Common Stock at an exercise price of $0.60 per share and series C common stock purchase warrant to purchase 3,270,000 shares of Common
Stock at an exercise price of $0.68 per share (collectively, the &ldquo;Warrants&rdquo;). The Warrants expire five years from the date
of issuance. The offering closed on June 20, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net proceeds of the offering shall be used for working capital and general corporate purposes. Based on its current operating assumptions,
Cyclacel expects this financing, together with Cyclacel&rsquo;s cash on hand, will extend its cash runway into third quarter 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of Preferred Stock is convertible into 3.27 shares of Common Stock, which Preferred Stock may not be converted without Cyclacel&rsquo;s
stockholder approval per Nasdaq listing rules. The holders of the Preferred Stock will be entitled to participate in any dividends made
on shares of Common Stock (on an as-converted basis) if and when such dividends are declared. Additional information regarding the Preferred
Stock will be included in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities being issued and sold in the private placement have not been registered under the Securities Act of 1933, as amended (the
&ldquo;Securities Act&rdquo;), or any state&rsquo;s securities laws, and were issued and sold in reliance on Regulation S of the Securities
Act. The securities may not be offered or sold in the United States, except pursuant to an effective registration statement or an applicable
exemption from the registration requirements of the Securities Act. The Preferred Stock and Warrants were offered directly to the investors
without a placement agent, underwriter, broker or dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy the Preferred Stock, Warrants or Cyclacel&rsquo;s
Common Stock, nor shall there be any sale of the Preferred Stock or Warrants in any state or jurisdiction in which such offer, solicitation
or sale would be unlawful under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Advisors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arc
Group Ltd. served as a financial advisor to Cyclacel in the private placement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rimon
P.C. served as legal counsel to Cyclacel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Cyclacel Pharmaceuticals, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cyclacel
is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation
and mitosis biology. The transcriptional regulation program is the anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with
both solid tumors and hematological malignancies. Cyclacel&rsquo;s strategy is to build a diversified biopharmaceutical business based
on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-looking
Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section
21E of the Securities Exchange Act of 1934, as amended and the Safe Harbor provisions of the US Private Securities Litigation Reform
Act of 1995, and encompasses all statements, other than statements of historical fact contained in this press release. These forward-looking
statements can be identified by terminology such as &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;will,&rdquo; &ldquo;expects,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;aims,&rdquo; &ldquo;future,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;believes,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;targets,&rdquo; &ldquo;likely to&rdquo;, &ldquo;understands&rdquo; and similar statements. These forward-looking
statements are based on management&rsquo;s current expectations. However, it is not possible for our management to predict all risks,
nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any forward-looking statements we may make. These statements are neither promises
nor guarantees but involve known and unknown risks, uncertainties and other important factors and circumstances that may cause Cyclacel&rsquo;s
actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking
statements, including conditions in the U.S. capital markets, negative global economic conditions, potential negative developments resulting
from epidemics or natural disasters, other negative developments in Cyclacel&rsquo;s business or unfavorable legislative or regulatory
developments. We caution you therefore against relying on these forward-looking statements, and we qualify all of our forward-looking
statements by these cautionary statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of additional factors that may affect the outcome of such forward-looking statements, see our 2024 annual report on Form
10-K, and in particular the &ldquo;Risk Factors&rdquo; section, as well as the other documents filed with or furnished to the SEC by
Cyclacel from time to time. Copies of these filings are available online from the SEC at <U>www.sec.gov</U>, or on the SEC Filings section
of our Investor Relations website at <U>https://investor.cyclacel.com/sec-filings</U>. These and other important factors could cause
actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking
statements represent management&rsquo;s estimates as of the date of this press release. These forward-looking statements should not be
relied upon as representing Cyclacel&rsquo;s views as of any date subsequent to the date of this press release. All forward-looking statements
in this press release are based on information currently available to Cyclacel, and Cyclacel and its authorized representatives assume
no obligation to update these forward-looking statements in light of new information or future events. Accordingly, undue reliance should
not be placed upon the forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IR@cyclacel.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !X 5P# 2(  A$! Q$!_\0
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M5K7/H*%%48*.]NI@_#CP[=67P^T[3_$-NDUQ'EUBN%#F)2<A>?2NX5%50JJ
M , #L*?BBLC<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&K=K\581\0G\):GIDEC/O,<<[N"KGJI^A'2O0F@A>59&B0R)]UBHR/H:\?\
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MI+_Z$:]'H *\V\??%JR\#:O;Z<]B]Y+)'YDFQP/+&:]%DE2&)Y9"%1%+,3V
MKYAFT*[^*VK>,/$D2R>7:*19+G[Q'1?^^1^M 'TMIM_%J>F6U] V8KB)9%/L
M1FK>?6O*/@+XD;5_!3:7,^9],D\L>IC;E?UW#\*Z#XK>(IO#/P_O[RV;9<2X
MMXFQT+<9_+- &+XJ^,VF:)JK:1I-I+J^H!MC)!]P-_=SW/KC-9,GQ<\:VR^;
M=?#RZC@Z[LR9Q_WS5SX&>$8M-\*KKUS"&U#42665N66+H,'WZUZW@8Q@8]*
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MZ&NG\(?&/PYKVF1'4K^'3M0"XEBN&VJ6'4JW3% 'I5<-\8?^26ZU_P!<U_\
M0A2:S\6_!FC0ECK$5W)CB*T/F$_0CC]:K?%*Z%[\(-3ND4JDUO&X!'(!(ZT
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MA)&Z*7QMGMI1\R_4>E0)I>IZ(,:1.MQ:@Y^RW!Y4?[+_ .-*=^9W]V77L_\
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MO$X/9E!JM_8>E*V1I]L#_P!<Q6?N/N;6JKLR4ZE9#/\ I,3>RL#2)=2S$^3
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>cycc-20250620.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCBebP9z5Z8OekhvWB6bcn6zycuE8xlKSkdK3ZWkfkN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:CYCC="http://cyclacel.com/20250620" elementFormDefault="qualified" targetNamespace="http://cyclacel.com/20250620">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cyclacel.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250620_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250620_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cycc-20250620_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="CYCC_CommonStockParValue0.001PerShareMember" name="CommonStockParValue0.001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CYCC_PreferredStock0.001ParValueMember" name="PreferredStock0.001ParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>cycc-20250620_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cycc-20250620.xsd#Cover" roleURI="http://cyclacel.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cyclacel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250620.xsd#CYCC_CommonStockParValue0.001PerShareMember" xlink:label="loc_CYCCCommonStockParValue0.001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCCCommonStockParValue0.001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250620.xsd#CYCC_PreferredStock0.001ParValueMember" xlink:label="loc_CYCCPreferredStock0.001ParValueMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCCPreferredStock0.001ParValueMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>cycc-20250620_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cycc-20250620.xsd#CYCC_CommonStockParValue0.001PerShareMember" xlink:label="CYCC_CommonStockParValue0.001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CYCC_CommonStockParValue0.001PerShareMember" xlink:to="CYCC_CommonStockParValue0.001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CYCC_CommonStockParValue0.001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="cycc-20250620.xsd#CYCC_PreferredStock0.001ParValueMember" xlink:label="CYCC_PreferredStock0.001ParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CYCC_PreferredStock0.001ParValueMember" xlink:to="CYCC_PreferredStock0.001ParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CYCC_PreferredStock0.001ParValueMember_lbl" xml:lang="en-US">Preferred Stock, $0.001 par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>cycc-20250620_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cycc-20250620.xsd#Cover" roleURI="http://cyclacel.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cyclacel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250620.xsd#CYCC_CommonStockParValue0.001PerShareMember" xlink:label="loc_CYCCCommonStockParValue0.001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCCCommonStockParValue0.001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cycc-20250620.xsd#CYCC_PreferredStock0.001ParValueMember" xlink:label="loc_CYCCPreferredStock0.001ParValueMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCCPreferredStock0.001ParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 20,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-50626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYCLACEL
PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001130166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1707622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Level
10, Tower 11, Avenue 5, The Horizon<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Bangsar
South City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">No. 8, Jalan Kerinchi<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kuala Lumpur<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">MY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">59200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">517-7330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CYCC_CommonStockParValue0.001PerShareMember', window );">Common Stock, par value $0.001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CYCC_PreferredStock0.001ParValueMember', window );">Preferred Stock, $0.001 par value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCCP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CYCC_CommonStockParValue0.001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CYCC_CommonStockParValue0.001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CYCC_PreferredStock0.001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CYCC_PreferredStock0.001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyclacel.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cycc-20250620.xsd</File>
    <File>cycc-20250620_def.xml</File>
    <File>cycc-20250620_lab.xml</File>
    <File>cycc-20250620_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "CYCC",
   "nsuri": "http://cyclacel.com/20250620",
   "dts": {
    "schema": {
     "local": [
      "cycc-20250620.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "cycc-20250620_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cycc-20250620_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cycc-20250620_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 28
   },
   "report": {
    "R1": {
     "role": "http://cyclacel.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "auth_ref": []
    },
    "CYCC_CommonStockParValue0.001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyclacel.com/20250620",
     "localname": "CommonStockParValue0.001PerShareMember",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "CYCC_PreferredStock0.001ParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyclacel.com/20250620",
     "localname": "PreferredStock0.001ParValueMember",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, $0.001 par value"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001641172-25-015874-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-015874-xbrl.zip
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MBZ!7LSH$^&<3Z@7YR>/R?U!+ P04    "  :B-1:"[*NW/,(  !E:   %0
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MG)(,'H@,E5L6K!;K+-0D ;%@\P6P(*5(:[VP<+$B;,F'MU\8?<X?BORL8-T
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MOAH8/0&M+N%XNB/>'J*[/J0V)'\\.@&=M,]##EJIB97 UIB#B:_P7[1!>3_
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M/1_6)).T(;-#ONBBS"1<Y$, KBV_P/G>J0[*:#(7;2#R7O2$YD0(3)DVQO/
M=EV%E'S/7PB?]37D,IKAEZ]21BT;PIIV4GN_F3)EVWK1 LUUGS;(,>M>TL:N
M7&$LD<8CW0$S*=[WWORP%YYW25.2D&*TN)"]=&0YBWOO8XO]MY#;%">CQ<=B
MOG*\4BWZ;T/G,0&A)#:CB'*L6ZM)MTMG#,;;P(NGF7C-'AF/.I>HY4]Q.%.$
M7:'?^V5MV&$N!"''TRZ0L.6>U]K.>&24AM#NO+Z['J^-AJ1IPZ3("?G?50L\
M*4_W=\Q%2FKF'V+@BYC%G6$^=!N%K0N+;@J^L[HL@]%G/)DJOTS+0K\4UK%6
MXA'%0[;2]$\+%664MH*(\;G"7L&S1"!.U+WHX;%?MF\ZZ@8ITW(+APZ_BZD"
M=QN\+>/10[^,ODD!I+_O3EKRG73H;<OWL'D%NGT#_YL1P.0;+MM:4#O[9%BY
M&X\ZIV8%-HKA\+*G!;NQ:&" ^J"(G\HY72[14K2<I70NTA(C#^4\PG[A%@Z#
MBQ*EI_R1D>&DGR"L]DS_1<ZU:.J*ATYWE;CW*C8=%K#6E"&I,':FQ)=M0A'V
MXWD =_<2'3(85:0Q1TS<0N!"I#C3_&]U\3F-66#^.RJ3HB%J*8V&+; 6>E6K
M-L&($P[XQ?Q.'V(?ATV\SZW)Y+1)"[-LTZ?"2C08V:7[<(5AFZJB.+8+$@BQ
M>D5HP]2X$8HR0J&.-G]!:;V4@(MP%QYBGF3"[F*Z/1Z9?A,&^DIAOG-%6\Q+
M\*$TMP3GG^\L^@?T-.&)Y'\'F1():8G!*LL71AS^,6%-=)"JD@LV17BL^35=
MAKAX2$A'L6&=9N88*J%)]2**;?P'3-:RR2YT61+.5M*X:=9&'#!L_S$UC/A$
MRS5E46Y1\S OTBLS%GLY]Q#_\!%?=IELNF]W"UMLBIJ_<HAT-DB(/K/, ^3S
M.,R:V!F#_K!-9BXX8BRC.@,R*Z8'8=MPJPH-ZG:"\KW0 IS9FQASC]U8N\9U
MOKMUG6]=YX_<&9!/I?JDB?R?L)#NYLS!U5B1&"4AZ7#,5F'KQM,L<23L);0H
M-C7)R56)T+6V)M8%%/0!$@@/:5)X',$_6&7*UAG:[#B3\>F*)=+]V"D$]"?\
M\>[U:1YQIMKDE6@/JLT"THX.>Y5: D&XE2P\I<LGCU59A. =K; BL83O<I^U
M^O)(+H;[/ZQ)P0?W/*VYYOD>@?WZ,UVIWA43#"+#(9=)IQ^B+U\I3-M><3.<
M#LL^@6X]+FRCI['QR+0F:EY%[H-N&Z31L5.KLOE&LEO-Z>U$6UQW00]?&KR3
M"T^:I*PYN76F_#$AVIF"6[\2L\;X7.*+0&]K++. Z37GHK9_1U4QYX3ST0&O
M1M>V);D'/T>LHDX)9JQCN^V>&BZD'G*'38939 (G+1>/T9S%H8._$#9>1\(B
MZK&\1$"M3;$3L"4,@"GY.D4Y"!=.1'ZM+H@7L#+E]Y 5-$=UJB9/J$.LO%*P
M_DPIL$=Q)&<WL,M(R*A1G%M)O0!M0!1^LDD[TX3H''Q&;R5^EJ!=(1F@3L5$
MMQZ)6+@TOAX6D:XQ,)02MQ60]V18DY64_X1C3AF>AY^%J$8R;NQF);T$8PM1
M;"*([9+0\K&A$VI3"/GP=,H!P1>'Q+3!.WX8[Z[#=@Z?"L5U3923\-1DE1:=
MB@ANQ1Z7-DRD04FT0DN4B6#C<SC> VG=,/$;?\W.C3:GK-=:T2KJYC7OW4R,
MJJ>+![\4%X%5[0J]< X=NIMJKE?N&JXT;ZY87)Q:%_P9@6F-ZV.(J:&S7:XE
MCA>*M:I9:KA<>X>9K63C"YOKD+?HJL4%^7SGV<T+6UAOCN'GXO@_@OAX8 T5
MBFB'MBTTUF%*1CJ"+QG@-776>\>'I()?,,#6?=$NW(Z7EW,:^$M)I&BJSE&P
MFPV,@C9B55+T"JM/^Z^R]1=U\^;.U@07'E&/0R B7%A":]^7:2$^ZFZ-QVZ+
M4J23G]1NJM#XL(2_O)>7:,#\2KN\)TR(/D1]TN(FXPGD0I]8+9*^[JSN([EI
MK_%1/=OZJ+8^JD>NR?TAIJY[T?^&:I%# XM2XU#C_3;6>:C;Z<PN6XT@T2K.
M+.TG6J/;\09H4+?=(<0GRE*Y$]$D=7"1>'LYB2AM<*4071(C8T[6'UIZ%!>*
M'.1C:$=$UJP>DA<_9."$1A]Z"!&)SE@>1JEV3'5CQ$B=-V6>5@O.CYK;?F .
M)*)'PM9O2DE$FK-96)0]#@/^+=[1[5^3HZ HR^)*(G)+F.8U7^<(]E'"B&B^
MX:;<H"%>7<01PZ9MY;QM../6 \#># Y,>T69(NFV6$[G!98<V'L+D0_KN"HE
MUY+S07'>&*)T\KZVZA(.IE*AF^T<CD<:Y%O2+LOQ-YYC!?_X'(O_Y3]VGST-
MGSY]ZF;#P_0SC,OQ"<!-3<HZE_YJLIHK"DG%"[,72J1G*2D'AMP<I4J7,\R,
MY^P0REUIY])C=HQ:1-F\AV]&@GA2\U+/%]-&UQ[+F)?Z;+.Y-?"L-SNZG3;S
MX$3J0[TI2B$$C,I9E*OJR8?/F8*W'N&I0?FR9[D(]E'@%5F/QU1#F+UB]T%*
M_O)P,&XL/_0M9#3I>JQKKWN<X#0/GCU]^HS9U);,9<1^4C+@=:95/VL[QPSZ
M>S!DT+E6;S<'S0G[W[038O":HY,5"+T(#AR. D)9>KBO#L](.T_!N:C]15J"
MN8$F!PG(-8B[)=,-R$([I!.Q+#3(4125*27TH_%!UXH38U=DKY<1,[%$M90H
M<K4.\:9P$>8>URELTHCO23,"7;P8I:%4\VWC0T0F=M[$A/>*IM4+>8G=Q&1I
MQEH;H(GI.).T?Y=I[U)A#</P 5=G@7DS/ F"E8CI6B">-Z(40*V%^D!XD3SK
M+>[\-9,A.2.&#L1.@=<QNC%L7_ P$DF(4[I*.X+YH:AVUYFVB?72. YS6YZ<
MS&8AGFLE&23I7&@HJVZL!2YG> ?H0RIQ\S;,+I000:R2!CE#L)A. I=6SAO*
MRWH\)4J^W>?1D]V75.$,?[O[,N$_IT8=<@47U^E!EC/"W5[? 82+Y?0$AV6<
MA)(A2@BJ .TIL;GVF1(U8<KYGI4@URB,.I#82:X$7F*#V%+DRE_"U:)+"DG+
M^(4E.\*@T]*2P'F4>[XXL_XGPW%([*[>XK6*IZY9NQ3=F:(G"L-$FDW2SWZU
M-2>NG_"V,F,^4;D&/6DZ5DRY*:V 7A851X')6."46GX2CA%/D59K.A,]X?U
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M)KW(5@*92J'@J@AT@J@[QB\9#*;V>*-Q0%P>L,/J\=U1!4.#>G ;^Z&>U\;
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MIQ(_HRZ7(:UD.M??'Q2]JQT[CRXCL!C$0D-!)Z)R/)*,2YPZ'-CO3<Y0D5+
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M.:$0G>VK631:O>!77IKNT%(S=DSV.Q9MD'<*R5YQA2&<1;HR.YRV#%410$Y
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M=LA*#W:82VA(31R\C%MRA5V)W>/%I?+XNG+41PV2<\JN%]9;=[T306]X]OW
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MP!=+I>0JX3R"OZ/\R?:@W?)!BUN%,FC[$G.XY2_YB5Q<+OD"'C&F@>WP,*S
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M[X%MZSE.B)"=E"QVV;/IUNHP29_<#1,*\%RO&PMXW" 2[#8&DK=$;@>8#4N
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MQ&R47,*#):>82IY*C/^L*2!C#QS^L$2?44K62FCR9.W7_NDQ>0,Z6\ 7^;J
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M1 Y4]P_>@4N%_A*>Y>HP0L-'S+\@J98S[.9@ M<PW=Z!E^3.L ([*59+5?;
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MRJC?,SF%A*J/TJC)IWQ [,AAI^S7=:"(Q87,<0#W2I<8H\T%S!>3U]#=0,Y
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M42:3PG:[RT36":8TYMEJBZ'N9^T0?M2R&3HK#EW/"<=(7)#*CCFL"4_97G_
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MA=;XTG%;S2"D'%@XGFDNU?P:%&<) %!:Z^Z57N<W:S:AJFJP6UBR0[RJ)=9
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M"-VKB'"^!1>4!05&QNU4T;;T%#(*%Y:=:36#[,C$!4'#?5I0Y_$<(O!;M[]
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M$JELN1BV0;2EG@U9UE38-W7<M0WY7Y .T'D] ^4B):@\TB.Z6T,;.!\56[1
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M)>-DQ*@-_+X360C595NS<S?R,-L.XX9]V2\.7A[_^OKDX.2<YWS@9+?<2 7
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M%_P=W8)K5"><R[CR_GVAX;X0DVT(DQO4U7Y?5'4Z67I;\##-KY..SEZ>@";
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M0UC\@96:<]CRG'TUH@B1E(!E"9]G6JMJLHEDQR?16'EQ5H=*OF6U^2LLPU_
M?]V_'[Q(DRQ^ LSQ/'D*/_SW(@'RAA\\#=[.R59_@@.(U'\:_(SN1_@ZN']?
M4C2>'9W\K&;'R[M?%W,GM'1_5-1U,7L2_(B?25Q(?7:0P=4)'L+>5466QC#+
MZXHR6;&CMLVX<N"B(QS!;G,O5&7OK=K5I\$9Z"1/@OTR&J7CI\&;:);PSH,Z
M!/OYT/[1=^I7^(V)/ZCHP[/O8-M;3F $?.;C?;8EG@!/P5.U3^7'EE/A[7CG
M'F(C?<(9T9XH+H#)X3;>B3MJ$8\\BY@,#S:&4<I96C[J4'/63J[FJ46)^2=D
M[P_V?GP0KO,O-V(1S:EI0_'6,]H[2E1C)JI#92LZOK'@9()* T6/*+1C&<T2
MT2&?)RKI>2':+V@7H!F=IU4M00Y2)(AR^&/2B\. #694F]#2K!<5.CA( 4UB
M?BVHHO3BVE-M\&=I52V,UM90FD1%9LV/%*>\Z0**LJI HM?F$3J#^KU6;Q#I
ME;0)HR6YI\6&$.)OV-I"^($VLQH&%@XL43J<KH3_X)6LX)'>ZZW*4?_A]76*
MNUJ,9-/0I91>I*09_V.P?_]@& Q^'?X3/Q_L#T.8"&SJDSMZ$Z^D85QUJ:+^
MM"L_KI)P!15$=NN>DL"-/!**93L)%,UG'NP];/".:\^F /)QTB8VTIIX9O>>
M_WW5;_0>7*/GN+),XR<@I,3=^/,O^^_:#,AT-DOB%'A4M@1N!-<P]CV%Z_UW
MJ5B>[0Z,P4/@LL:+ :89,B^2J\;W%@T53R7G7APM.>"E6*!K]);!X-$PN.([
MY0V8%K,T 77R4,P3#+CAQ(6C :]>9%&)'DD:=5K "(JK#=R8[?L%[,J/#QX,
M1N2 >T\_I2F\>7V*''ZVR,[)FE2Z!S#R!/X699A&H.-X671940"?]M):;VB<
MQE.@[:2J@X,T%M>K')"CX\@QPQKS<3H'IJE>]CHJ/R8UNGS+!.UN9IL'65$@
MTX6M>;7W;B\8&)U&?^6$RY6;Z[*@<Z#-41-1HM)P?.W"U1[_;M>\.DAT1[6>
MY&I2,Q01+\C_M.HX0W6>0 BM*Y),#_*$9@7[*S:A#YO:-+VF:<M%W/B*]7OI
MQ/G%BDV(&C&'C79LW1U2N^%LD>O8N>HN^83^U$TN=.S#G;3>2>O-I/7!+9+6
M=D90OV=Q=,<36XD!*G%*$B-/\6;O[LONOGSV??GUEMT7'0+H]WR[%S7&RV*1
MQ6A?DI&,XI220!,G8\*RA3'$-,:0#QG4J A8":.-AT7RZK==PGWL]URK&,UA
M\T09<?06 PQ1,RR]]XW<X5ON*WH:C*+QQ_.R .:+OOFB?(*NC3JY]_RD28A1
MR>3'!@)13,O1<]P9G2RH_EOQML -M[61J-+0'H.&-OA)9;LX>8'[XSIL\PZQ
M Z:./NJ HO),P73'\$PT1B\5;.JX\AQ,&%%'74W[C-RP)DV9##;2WVD(_'Q>
M5)0FJ1,*V/"">V4G7^R\I%NRC"M$U1[M F@W&4![M N@W8U;_-7E%RS+.'72
M6&P-RZO#"DPH)1Y+<C2$RHTTQI3UFI(X54(I)BV55:T$A'$$C+-H42EEC)P:
M6#^(CH2TZ:KJ]]**XQ-92O8-C(ZN?4Z]B#S'%<]GE,:F)*/A^U(A$O)#@>"$
M*U-QM8E\D2<H!6O+V8E+'?9[GG-4?&6%'<)P1NJ<>9=[+1B,*%.HX1^B*IJ?
MGCQ^$$1[L[U^#TM[ K^R!T3F]T\>/#+%/_X3PS! %R3L\MNSP_]W@!/"O_S:
M]*':NWE19(L9ZK%H5^#D@?7A]:4=IC!,ZQ:33D/.J#7[BJOUYN.XJ&'2XU;2
M4-/&/>[W&IM,YRSK:1D"%"AX)RVBTC3AO#[BW.3<G!5\A=K,NS3_&+R=PS="
M KC"**A2N'<11J;*\RB7E$O*B#X'IHPYC^-Q(M[S@HK6)HM\7*N4*!X%O^5)
M#7G[9T554_0+]#-#V$[XNC'SJM!S#BD_>Q /24?$?$DR-C"KL0HE=2DMD1/A
M0KC4CFR4]N X.;;M>PXV"S*D>4)<"8^MC$#O@]DE&:ANK-^>%P4P%!@(]%+A
M#>]TB0@/-XM^+TJD5(QJHG!,#.NP5%8Z#SM?$,^1$\V 5G2^&AIU;C*DK!6T
M3\Y52S[!E"75D:^O#CO.HU2S,)5*>>M5MCLOL]!K;DFK?N^KB"N/Y]/E6R>N
MX@B6OIK-=@JRC;GL79)>.%5FYS\#56&^ON+#AASH>[>$L]0__#4X@"WJ]]I_
M]JM?+?P'9>-FA\;AHYN4C<T3;!.-1*J?)QOK5MEH51GB=_RQ>S(@S2*F)MX-
MF(8\)Q7"KH0-;E[ ]GN;2]C@Q@0L^0TWEK#!30G8?N]J$C;8"=@[(V!C3H![
MG0 QY>+OVQ6(;GQP#[_:P:5[='!'5DJ%Y^;]@%$/-Z&Q68(R1N6GS4ELZEI,
M!45-^8)4I*>+,)FCGZG"O?WSQ)1)2<(?L()QF2"(AJ0)H"\;:RS:LT0$\2-.
MN$Y%?SZ*,G)_JU^3&QQ7=)20?[DH83)G)6R_7F,]+8O%^93>)T_AZ[%H$PL)
M(RP8#0[A%T6< A^NEB!(9[9(._IE_]!5%R8V6]-*5,1>?$RVP=P5Y?.7%Q*_
M3$EN#/:')FD4AER;-#I'65'KK5N?^ GKPUK.S-CNWC-P''(P*-@.AEZ J^'B
M#R[2UM@%%?K6"M$ WJKJ_YP\GZC?$]"7,6GH5JA!"BME+_4YL^!4SZFG\LA/
M*_())=2J3%>-$ 4E&OFH%EZ,DP/CQOE4U5D<E[@-ICQ4!)UZ6=Z5V23/H=Z'
M=X93V_"33>J&#9Q,=]%TQ[BK:XXI&>XJ1<>?,Y6!UHQ9F6A LPC<6*"YFH]0
ML\=<;7TB64M)YPBG#&MA_9B8GV#14-H9< >^0%C.B.6RL"?,&:=";A,I#>RX
M>\2/X"]SJ1E0A&9=KF9):ABDI?P&F8!3(3K169/+]B%#KKJ+*6,<"&H>+>FH
M5$)95[7VH# 1:2'8L2[':]ST(?EH%3Z3*7']\A7O_9XQV]>3 .7OVX0)^G-6
M:8>!E"_"0>D*=T=JM05.N2"$V$BTXHX[/W.).71FQ(0YCY9^QCYL,)X#I?YD
MZ;\7*2.TQ-$,;*%* <KT>V@M@HC(HZQ>,O]+(B"Z/STDK*2F3F"5M+CLS=CV
MM4Y1[$XL;4];[/>:6P)&V)\>/B!_IDT6@S0?XP&(+?>G1\U'%&[7- 52:&>&
M[?O,L'=#LQO-']/:5YR2%*8W'^/(OLF9A"&$7."[,2A[E;NOH*2UQ,=AQ;K:
M.#*@!Q'K3B(:')5"7=,7^Z=G>.G/RVB&1FJ&$#U1%7A%W_CVRC;SE%.49H5G
MM1?L"S@1EYJ$%C/NOH"-<!%-JE+/5^;Y.3T?HIF(\I*E?627[]HL(%2G[>L"
MP!=FF"[@>;5\5MOT7U0XGJI'=XDVUG32S3IV5L^66CTM9@_^6J>GM!@])UX*
MEP5:T(2'X(JG!H\.52$8XEVP9P6NE%U:3SEF!C7"SQMS=&"OJ&R=D&^73U&0
MFX7W>PGJ ?E8"5&! 7(59L3H4'7Q^/$B-U:>Q^80QD,T)0\^*!3%QAI=MA2K
MQXR'3*YG19EX2 YD&DAZG7G=[JIM[563N_8>)5N%T [!>Z(JZUKYRA50F/$H
MM#@%Q'6P7M5J*4;H]Q2PT89J5FZ/<9G:2"5T/;CND,2V)[5W-+D=R[A"(MKC
M72+:32:B/=XEHMV-6[P-DN6"!0N*CB2OV..)FL;!8GG_A-#=7H TP< O<&A\
M6;94['T#)S>\(8H9LEEA*8E&PCJ1J:97<&3:ZKY1D=919V" D\@@\4'\HE%Q
MD3CB,+)K&7R@Q94R40*_E@U,-I'K"U6(;A2<1/_JJ"P^>LKC@&&YL&Q613YI
M'Z*Q"MEJQ[ .S'M>?GXK7L])6LXL1[)&S H%ZYFVQ;'N+)\->MJ!@*J)&II"
MKU&6>'[9#I>=[PN.<K:XT=G"'B]4J%&W[_<\ATED6<Q,N"ZFKE9 7&</!@#0
MX2,>GA:R80 JHD8*NR(X(LUS\&EHTZO>2@9N\]"JT<.2+<AH-EL]AEUD5:Y2
M[Q]JK[E -_J;7156+"CYA!%XA&%?#JW).B ,,T2<FV=+'!K=@:L\\NSML'?I
M,C(DV.V<2ZF4(%>*H;Y,!M2RYOH+@2[%@M5:YP9AD9 ^^2I!DP4%-4*#X:1+
M\?<[ &ZP1&"2S*MPC@J;E&_5X ".1E92S&TX,\5;)/Z#OA8*[O!TVJ'/R%<#
M6W != S_[-P\/#F)O=NT"?L1<7K(M,@+W,>! W?HN?Y\[[BHQ$E,5[?;.6JF
MU4XY$N7@<BQC;DM9S#1R0?AJ9O/H"\Y2<3,3^W$ ^8VIK$_#@HC;"UZ@S^]3
M!.](%#OO]V3.!O[0H6^8&>5!M%\C6-.?'K(W%05!07!]2E#Y;B@L\*KK9#:O
MD]BI-^MB9/0"_)7VU!/KXJ$WI4::(H'CAP(PP"EMQ&J$LBR0AW[/)"$10#!*
MHR:?\K$](X>=LH/905447S8')-PK76*P.!=<0LQV03\(>24-"T&XP*6==F)N
MNMIA68ML/I"#M'<P/ADW7T5<(L93/5-19]K+K*@J0D*=TE0<*'9J"A%$/J?5
M9B/)X\36+?#JI(FK70#]VOB%<!FRZ%*@=7!O*5M'N'1(Q% L:DQU5ATIL'-"
MG(RQ#@QGS3'',3I7$;N8H^%Y_!V]\7?*A:) ,ER@29>/U'&O3HR:)?=/7?<N
MBFTII;3XEL6Z;8V%G%U43JDA%&^Y87I'-7-1S,'D>U&R0@4<480-$-GIN$SG
MK&3#(Q/S2*4?P3XA<X,^CDRF^9SF,"(+=),6(\$\_RF%*T295^^ST^P:BAQ+
M'2L]P86;TGQ4W+:6/'2\OP1H+>Y?$D89JQQ:GB-?E()?"R/.95KT>D;XU7-O
MQ[7E)]4SHDBEHHOCM+Q +N9Z8$&J=$DAJ0P$(HCNM#6[N[:M=TW<JX=P2N?X
MX%GT24*[QY);*?:LE?+36LDK6/Y*@% )[[DO1U78F[5B3A!F4[:./E%R, LR
M1 S"%1.L-$VC103;64@M0=)0(7?+M=0+TTFCJW)%0PY6M@5??<:Q.C=(+C9_
M6]*?V$A*P?[&(*?&M9_!\Q1;9*BT"CR D$YI6EPF%]QH*@P8 EDE05SHJ&U+
MJ)A3YLQT(YF.2<!H7T#HAH\NJ09*AY<D,M-4X='!@)MH)2;M$]XSL:47U/"
M6B28C@=NIP77:O:1LF'G,%F81#S#DICV6/@@OE 5M>M4%.#1BQG\;P*J2RI>
M$U"U9B/0$!)4D11IVA1ITZ&\V$E?%,;,_#?+?,<,I2EK7822\F&+[\<$_%6,
MDZH2N*]VM'RNOX?73A*#IFC2# ,GRQ",85H GRDHHJ#]I17N\#A+(D*ALIM>
MB?)&ZK?DN^LT]F''G$GLE$4.NM_J8.&.VV\MMU?L'LP.H;V#HOA8-1-S*5*%
MUCNC::':4:'N+6EH(_P59WD23CVK$G@W\SQ1_@!0OY M53K.S'>\7;D*MU)9
M_^*M$R7BM#[4]/TNU'23H:;O=Z&F.\9VOUYY2\+E+9X;1XOY5Z;W9U>!!#)B
MR2/##[M0I-@-'+G.,'+!2LH!Z$W*>61Y-)>N"[B+)^N@D!-:"16[ABW4.B@'
M=\1W*!-7EJ52VT'!IJ?L%E"FU6"Q0;\C)[UZ4!?G"2D_V@_O;?@^Z'X9NA^K
M4/<AH67T>^^2LD(G+MJ\G,L8!8BRA 9M^UL#41?;JT?,4))N+@/8"8[[=5VF
MHP5MZ3M&7[)C-T-0^16(6)Z@UDH]C8I+,MLQ!%+IS*H#_43P]A+D;S5-YQ99
M.5"QU%MJR$YJG7"NZY'+Y+RP?;*-?B<=\1E_CJU*/"H1UL[@1RV;H/.XT">9
M6$Y^4ADZQM\09:T].YZ#D%(0R3NF"U"X/QVVI.5IP<;CM*2@=MVV\/L[L. P
ML.H[,3EKECRQ>9&;I,"."XH5 FLVWM"IM_WP1=ONZUQY,[42[2N0RY45)5I8
MD\/Z8I@M/U2[LS7.:0MCV/616U%"[7\.'/>S?H>SN<<Z. 4FBYL5;WX=,-Z7
MGKW-;_(H*\Z+A;:MK%\9%'SQR%]MG_N]M1N-W1.QR-5E>ZG"3/:#(Z%J*&1=
M6 >Y#)/<S21IBL0'E(TZPO**;(R@T.($Z,!R>_@8ZXSEB&".TR@'G6)_7&M#
MO%QD0BBE1IFN'(CIV@HXI#5?)>#W!EO.W[U&!%9*RQT?KA_]4RT!U+KDXE)8
M%@-X'6O3*=>MBS,Y"* "H\6"[ +6EZK.!R25T7=!NV"'I[ U=9HU=I<V Z<!
MDMT6E1*:[*2\-&^>L<*&$% 'AV>1JRL1GXY;3&?EW%,8MDQDNS#YI'D]6\C;
ME8.X!^LYN;0.5QZX#A[FS<^B5[D,> Y!G%;C,FF+::N#HZ:<E>)1K94Q?I!9
M2DF;\MO96**7/["S+7SO,S<6%)7/V%ER%E(MBL3?G0[T:W2(T'?#J7,BU3(O
M[%@PO/$"5>&EB [*K2%M;@Q;$8V7VF/K[+.3-,5!1YN\(QU[8<T,$QBP84E4
MT9U)X,83[^%<)>NH-03+S3(]4@F<'( UW#K-]>2:#?YL=(1VY2(TBC[ZDDOD
M54@B5WT/!TPG!N9!JH,;<5H;PX(K:](QB[T<(T<,5<$<T$J&.=39/B'7"$F9
M'_N_0ZK]C>#=5&W+[UX *8WQM<4"#HH\N*YSGFJ&#_W?>1%^515N_:9N)L]A
MM1#%!TG\;J3465LJE:#X,S4ZVD8E;4>S1J.M[DXJ&;%LT2X14]<&WY5Q!2.F
MSY1IJR3<8-8U.>^=N9^PS\XT'[T2V;3=L Z[CPY=*V$4YW$24[HTP]!D)GAV
M:4/WVDRYK5*59\(5T)&-'$)AFJOLP*4%4L16NY6,MYJ=.B!2TOHSB?B*B-9L
M*I2ICRG5M_[*-W,6?4IGBQG>0J1\]/G(QEV%>)VF*])7H?7HG$#;9]E?I/",
MH]P*1[FDK--/6*_BG*B+PA1Z6D[HAAUA&INT,VMY?&-P*D0OHO23W,I3)<^!
M\4IXG5.>LOWTVS#X?N^GG_Y\/<<B%ZK?NZ%CL3.H))M)>*@/OD.A-ZF:33@Q
M3_Z^B1NBI3NK*Q'=0O(-7DD@%]CUC,*?DA<:_+1NZQLGO<GV=U\*W7!\@SPE
MNPX_R;I"G6MV2L&F%&@7+>B8D"27>V!WYI3.Q8<B"O2Z<]&QGE%B08&8MM@_
M/GQV^N'=\ZI^]AW^26V1K/1ME5%GM7%AX&U#.4QAJ[KS&G$"JZKJ<B&]C%/,
MHD050$6N)<)DDFH4@ #\*(7C0<&)D<UZ2<R$=0 71M_92DJH+$LZ67=& S'V
ME';-D:BA< L5OT_4?E&P'R>/B"'*UT24@A9\C)NR[B#$UV!,0&X.-4,$<U9)
M.;UI,9=- 2,Y04<@5B?3;:S24J7]P6Z#?,BXU[ A7DDA-Q8GGXWY=]5B@OK'
M1-1&9,=X:%4%HQN$"I>YG+@Q8OA*.X_8X"-W*S<)[_"GKC5.@ =$&9QRCBR:
M#@$[6RF/ ,A/3]#L0M1;LHPK%-?]L(MXWF3$\X==Q/,;NL77'>-$Q Y5"/.8
MPYB89P*DC?@B^SHKM=KA^6UQI#KB2#5KKT<IE2[$;$B=@LG37G5/><FJ>@:U
MHRQIN"$M!?L)!;[FB+D4L3G''7.3/'8"R_T>ZCWX4(R0=,J41S7'^G=%'?RT
M^HUN %>S+ZWPD90[%/IO5GV39<BI&I!4O;E9@3 @)5" GR^*-%:&6%PL1G5H
MA=Y5'%,\/EU66N(GH+8;#[K'SU#:<5:+$>]>M8G' E11"H]A:F[9,(U"Z0\Y
M+F8C4/\JIWP/B^+(<8M)724>#Y]=A70QO,+@U0Q1/=I&IP:5%T/>#X((!+4\
MBZJ*,4O$P^V8<?V>Z\IT-GD<S5-,W>2)^JXE=(BY'O&ZF=MN<IMU&CP!TCOY
M_T0+VO&*>F=AP;UM9/\/.*Y,CBZTW1;E4F^+*I'L,E*E\);K!RXHL.1$!SA2
ME!?D2;_RS%:;QF90$R"P.J/).S?T#IE\;#!=V.B2L53?0>X KIP#G=!RC2@Y
MOYF#ZV!]L"T5[P5H+5L5$Y3 [J8A6N8B-KG2<R1</F,L-W>&H_F$U$=^HXE"
MX6X$[1R75EL[<G8^63S288B4IGZ%62DW$CY ,VN [PE/89\],X-(\=XRN>]>
MR9TLWU)9/A)9OAA5I,O7 IP3O(7C1\]JU8E48*Y$*P8.WP2*LS%WLL2_+<'.
M"0TK1.1&8N@%P8EG%3W=E<I!1,83M4ND*@YY70K$5N@$#539"+L\:DJOQXZ'
MD3+Z^2+V>Y;CF"(?2,FKN'+M^/05VKF%0-12:6]#_7@%7]&8BQ;Z/5ULQIXI
MRZ&LTN2\P4*/XWE?-VO/QJ;B68:-%;2$/#&-<$?0";F1(."W&#9..1; R[KY
M^4 E\^"<RUA1E^UJLL0!%[\6$SOHTY8-M(%'<]@F'U74QSC\(\6@$0,7=,W<
M,.ES#C,9)V_)1=$J<-TXG8*1.W(Y/>_%H1G=#CE9,L*BS"Z=TU3R6!$WA9M@
M37CM;(.!7UT4M!<7*6@2.[6SQ3MG"I(55B1+%=+&FN-+/IPX_%+GUK +7X7#
MS3'W>^U^/__6&;W;K[5TI]8V+0-'2JL=$*9)6T*5VM;N>+KMSEP_U-"T1U\]
M):T@X:VEV$<T2I9$H(H.9!\LZ%!DRT2;>+H48$0C2<Y,RJ_X1#CAZ@JG8BY?
MOV?=OIU*L*4JP9A5@G<@'=^C=#RR#6G6!HX6%'35E-/ =76-^09<$9-HC'9;
M28QHIMJO6@JLRCES#7NVWD$B)\BB'#5 ))CU  5N&DRSF2-CVZWUHLPMN]#4
MFU(<:9,L5'_"#(]<*4^#G_ 5&HT$OYVSS#-3BO2F@$I0S3$-9#()&U9O:&&$
M@W&(YW!.X9^0$A&Y:M/ZV)J*U/99N$A#%S3()@%'H2$D&:W6&9O&Q?ZW<S*0
M%YL<,\G,[ )!7\>;[7GI:"*6(G8((QOAQ7J?I*)B.QI?]PG^B.HCFMMUZS[!
M'U%]VF7B&MUGLDKW:6[]1HI-OW<ES::YO:L4&W.8@EC0F&-3G>DJEFZI5/DC
MZHPS>+<R X;V6KEY?<J,,RE7;^#:8)E;FTJC[*$K*#0KAAN:- :3EXK?]WO.
MKQQM)FA39GBN7E#X<W4;TINNI-S8M\O+X59$Y+57X#-+&,E9:@9*S36L,MA8
M W8I'.:6*\B@2RY*US7N9&W!4TTC@W45NW'\G5*W'<NX0L3\QUW$_"8CYC_N
M(N9WXQ9O@6DF+?!>+/(XFC'BR)E1VE78]8JAUI!"K4[4B_%F6!XA!A[_B]1V
M3$%'VTQRZKF:PK(<*HDLL/]VEE ,D2L\B!-$MGPR.!)8S%M*\$_@2;@:-C0]
M>:P<??P#?=8IJ+ EPO!TS=B>#'J[0KCU9&YDZ1CQ?5 =4* SH89U"3D1?:F\
M>MH0)5@553Q$8)P8!\&=9 $N704<(U5O&@9-X& 3:0':W#H56K7.P%Y/:&$J
M3FB6M>K@,.%-3J0F!;U/^-% %20U*R/<7:;FLDKS<!'Q6%6W]/.&5BY]WUCK
M1-^]FICD\$N=# R7*K0^4CF:AC"!DQ66BQYU1-V)BOM]FABX-:=S8)"U@BGZ
MX8'.ZW7ZRO@A_ZX?713<FE4EU%/<BW^K<@.\*#$%I#>\09@ISCZ/C6Y0T\P'
M&]!K.@O/L+-"?]:6O<RW!@]YD574@9 !Z?0!-4^]\9*T,H%#@D!5Q;QT<ZW3
MCC<\86D*O_GV!6MW#SG-8C;CTCCC=N'%ZAM$_8T</TB_-UI4F-%0.>',M1X?
M[T#"QG& ;CX'P4Q>&\,06YTR0TE'=F\G$RN6L\'3"H7@$BV7D1B;[4^+0ZS:
MY'IT(N->XT4)!N3TL3U+*T29&S53X3"VKW6TLAODHF$BMW74H-"YU8W,Q21O
M P7F.*4)<+D Q;9795ZFA08C+K"HL4QL(+J.I>N>.VW@S-ICA+4O[2XCO"-.
M[GKA E;Z.S7TJ[JZ4CRDM$9G<B-#&4O]3;]GXX8598-#IB@251O):E%><+6$
M]2L#MZ$"S5'F)6E[D=9]G<M]:#]FTPYN$YXQG5>;AZ+C$#A]Q\Y5WV"'#,:U
MIVVAC\<4 +?2R,K)K'43;GKF)C&L67NJ'5<NNF@C$655_A-V!"]@35Y"CJH\
M40OM]SJ.+G!:^QD0Y*[']55T<1]11%2M/<V5'\S::6S$:U\^#T=0ES*(9Z5E
M^3!/\0MUSC,GRI/.Y8DJ3Y&"6O$J(:UB$1HP&M.;G<()J,LALT/9#6O+3;>L
MC@$I^7*5RH;5'E+7.2UH#0K? K2"50H9>V!UATU:6"<C:W=5CM3PVEGOS\$L
M"Y4V9R-K-785:''0Z5XW+3A77:_N7M-R)9C?P25&Y^IRY9J#U*L3M&$J#.M#
ME<?E9:>:K1[3*$XG9[P_0.FSA-1'5=XKE@:)"@MBOJ/<T=H61>*L--BS/RK&
M"T[HV:P#B)?Y%@]='5**G;6J1:^=$+(GA;+)<!HGYF8L38>,HO0ZC:J:2IB!
M#X_0[VD.N<BM:Q;#?5H.-V2R.D-NI0#N:G'':$MB?+$_U=YQI0-KC<@_;XT
M+YFC:N]2*G,C/=4Q-'70KGU'.2?#065-"57+@:*@O&0N;$/T$E(#VZ1<(T66
M-K*QA(%46,\CXE9\74 $6_G3*D2W-GF(JW*UZ%Z=$KI1&$TEJ71H09M1"<L'
MU0M!OXR[($C,C+%77/G+#VCD!XI5>MDA[B8/$$RJCCY20BUY1:25/,?,?#FQ
M8E,;?<*[9)_F"_JMJV88^J7P72O162O>9C!REH0>^CU11?#W<,5K(Q:#!)3
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M8P7(S6)G9V\Z6>V\-H/#(]-TE(JZQAU(\.U!^\L9AU&_UC#%-#=3=)/M5)A
MC22);C(.A6E5VIQ\%ND,*4:OCZU@@\WX2^L92K#KE@J["[6E%RKG"_4RH7(*
MRP*9RB>8C-5LXX!"7DEUZLV3I\I)5X*^7/(_<M7\7*5NA@8!FO&*N 2!X)]!
MZ=;!KV^*=/RA^0V?N3#V=USG*OYORW^W?4UJ_B?ZC$YN\6).G@]."<IX@0EK
MY/!Y46 GN6KX[$#[T<99$I5/@E%13^_!0GG)M_L8O\8%$\[QM;R\CW9>WAOU
M\C[Z-KV\S:OR%2Z 6><7DO</KU>G.GG3[_UR<O;F^/0T^.7E\?OCMR_<O!-$
MT*:&?QY^MM@:%C:\55?,J;.+7$'(VY78+ACV)"VKFBL/T(444[7+G06(-BS*
M9DD^R[KR4AV.U<G9[M$EM/C7Y@.T<+I[ZDH#AU&+A;_J#X/#M[C(-W^_]\AF
M$M=TO:_OJ&0@KI<J2F!KB_D\*1'C!P8Y>'[XV^&K?3BAX-W+_?>OX6\?SDX.
M]U^=4J@"Z/2@6R.Y=6MM6XV6(#=$/.I]0L,_H!1LI2?ON36/7?GR?(]OO'8]
M[,94+EKN-L^VA0'>U)Q)R;AA,FTEMN<'RR?MY+=:6=U\J6H?;\O_?Z5S()7X
M\QC!==+^$9BU'X.C<B\X JT'=*8B/]<WX:MLT!D&RS][APZG:3)!9%'0^=!Y
M^Y:U/6]-8FG<2JOV0&]?0Q*N,7(?[XS<&S5R']\E(_>VW(>[X0V&6_WF+6CM
MQ_W>VQ?!\:_'[P]/3H]7JNZW9V6=_.JN4-N5.-Y5%R;LN)T9NTSK"BQ1[PU.
MW[=<6N)GPD*_A)5W5CQQ-)%VMGWMA[MR3LK$[O<Z;&PS7S)(#:._C72^<BN^
M5@[X-7L5!P^'#&5(F0'24$O2Q1*L\6)@155*\"_YKX&[[F'&6UCI'EA,8EI7
MJG<,,*3;[Z43"^55>N0) C/E?965QIC3T'2J(;W*5^52!]TQT&M'AJ@T)O7!
M;6X92GK%775HWC[*?#3$<".?L^#F(Q0-GC>!G\#9#X".$!G4'.JH^#1\LCO"
ME9@G>X\VS0NYWE7]H]_[R__YVZ/'/SW])P&11Y=P2RF)6Z-*?<@I:>D4Z]NK
MIT%1[HYR.X]2#K+?^V?P#^Q<:JHWITD[.GXG6DV$(+D&"R;L*MO$2[_((A>C
M"SLDJQ8YV,(C[*S4XQ<IA$\13+/H4SI;S+HG)Y+/ZS$H?<]\& >NGXXI4:)C
MEM1G9"=CMD7&/$89DS'T&8&/47?3)LYM[34 M+4EKG G&N?Z9GJ0J=KTBQXE
M67&YDTSM5EV[-Z?=)O?B^'?-Z'R$;C[[:2KN<$)H5XA>R$L?4\ALO1GIQM@<
M__0*:^[+'_HM,R0%1-]C*Q8NE8=P,*'\.FI)_LO^8; /PA!!'M^0D+H^'O('
MSN$;<2'A3#[W/C?NL![CD1<Y_WKWF?ZXM?Z9'1%M(1'=/C+Z6FX^9V.^W@IW
MMV=K;L^7HJN;2(7=$FK^Q^G)?[_9/_OPGD.(+]^^.CI^_\^[?'_O1)G"E3C4
M+5O;/4IZHF+WD_PBX2Z3QXB* :_ZUS7]=^OWZ/8OX.2Y52<%AVTWN:,O"H9(
M\8D :Z7^ "'<_@V[[0O0U[KMI*_E:M_Z+;KU"Z!TS)L]Y-TI?_4%'$5U\J3?
MNX[#O),'W*ICKDFS_?X;3ZYUK%D_Y_[6Y+]^HW&IC>P\B<Q<:Y+H\:\O3PY.
MSOJ]@SN<*'J[DG?E@\L$C_M)D",F7W;O^?XINAI>'[^!PWKQ]OWK*R]R5&3Q
M=JWT[B#;GCP?G#'@(@RJLD>X!YMIW2$ET9PE0BEE!"NSF&.O (U-GN:$PHC)
M&U@EQ(T\*OM7=H(D-Z/>&ZX$P+A%VV@CF-SRU< E[?=^WG_UX3AX?WQX?/+S
M\5'83AI$!QB<%6!% Z18*Y3/,M& GY7D@=3%K=^B;ZD6_@]/^/L?_OQ%7 M.
M^G]7=?6C-=75UU7>^D57_^S#<X0,VV3]?VM1KK>&8+ZL<N64D5Y/Q?T-+V#
MJ7<\P7=EFM?#M:OYIDYX/XY!FZC:.<$7NO=?\:YOZ[G? /Q$US[?'!S#E_4*
M?M$E*)B)ZV6'7_#4;X;#;OJ?QXEW%'C-%+AEK.SZM_L&KEXK5L;6[NF[:9'#
MI=,)NU]<;-^V#5LWVV^&<HYG49KQ[XWRMR.?'?ELA;*.<=+X"<_/BW'"O\/
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MD5OL:OQ!= FWG<Y"&PE:?U&/XKN&26(,03K*\2++0KHN5]-T-$4R25J6U[D
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M,9@I0HM'1?&I:N;/4L (K7T&#D6UI$)=7;+%AO@K3L:D#D"L:N!=S?-$^0]
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MR(1P2MVP1:9C=VNIK6A76LL]LR!@?<IM1/\%FL:)%_B19]513*U-DVQ:<5X
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MGY=.R,P1Q0>G8-#1&JVB-#:R4,?9)$;0+O2TKYS8Z5*W%XUF8I$X;-=<?(M
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M],._[N-*M_H,'VQK1(!3**B:]RR_3+@-W2G" ,"KUK"+C?_;VKUY<?;2*H^
M/;*;0]$7!4,I^'N'=0=?L'];NU&:B-HVZ$8(:6NWAG)*;G=OMG=S3J(Z>=;O
MW<0>W*M]^1+PI^__X#DO3GZ+VL!=6LJM._M6)D;LJDJ:R8 $^7*[WG@XD]-?
M7I\=G5WPG(_\JHS?G]E_L/^D$6G ._E5PPS;GN*XS4E>\L%5@N3\+,@1_RI[
M\/+P'$W6GT[? NF]>O?AIS6+&Q99?%=7>#OGLQEBP),;=OU@J?<%XYK!N"J8
MRMV)#%"]U$IRT)2R+PA] <ST;&F0=M.<P,XPEHG9[0Q;7]F_LO.+N.OI_E<L
M*.\0>P?[W\]O- M[59GY5A()W-=^[Q^';SZ>!A].CT_/_G%Z$K:3"M$%AED$
MO\S@E=4*7*],-,Y>)>'0NKA?!+"KI-VD!/#'/W\5_\--U6W(M)_\^2N7P-Q<
M6=Q7W/AMJI+[*LN_$P5HMU9P=0M;N,<Y-E)17J9Y/=B1TXZ<=@SIBY9_&,>@
M;%=WKR;VJPK '8WMN-2=YE([H;<CIQU#NJGEOY\6N=PE/Y5SBZAI)_ZV@]IV
M_&I'0;]O^:>S*,UX>CM]?4=N.X:U8UAWFX(P32M^QO/S4JS@WV'@95OM*&Q'
M83L>]>VW\ ]%06YK<9ZG3MY^MBY!=$=P.X+;L:QOOX5_* IJ8UG*(%R;TKZC
MMZW,'OTFK8'65 [\\#QX-Z>^D\^"-U%5[PH)KEE(<"?2^K>ZR]0W7=*CHW<G
MO^+-?_3ZXJ<W+_\_4$L#!!0    ( !J(U%IR6GO'$$<  +3@ 0 )    97@S
M+3$N:'1M[7UI<]M&MO9W5O$_X*9FIL@J6/$2)S-V;NK*$IWX'45R2<KDYM-4
M$P1%Q"# 8)',^^O?L_6&A:02.2/)G*I)(I)H]'*Z^RS/><ZW/US^>/+=</#M
M#Y/#8_AW@/_[]O+=Y<GDNV^_Y'_#MU_*U]^^.3O^);BX_.5D\M]?S/.L>A4\
M>[JJ@LMD&9?!:7P3G.=+E87\01A<Q$4R_P(>A$??W_:YU\%2%5=)]BJ GW[Q
MW;=OSTXOW3:>S-4R2=>OMK5"ORV3_XOYI5]\][=L6JY>?_LE-@BC?-_H7Q5_
MK)ZH-+F"-Q?)U:+B)OZC7?[VS7>3CXMDFE3#P8N#9]]^^>:[WO[_QSN[97Y_
M5_]>!^ZR1'%6Q<7K8*JB#U=%7F>S)U&>YL6KX&:15/$=S_S1+T<GAT>3D^'@
M_0^'YS_"?_YT^>[H\.0B#-Z='AW<_6+\QP;[Z%9N<G[Y[BVLU>5D.#A[&QQ/
M+MY]?WIX^>[L%!;O_?GD[>1\<GHTN0CWBW@_!P.+>/[N^Q\N+X:#P]/CX.3=
MC^\N>?WV*W8_!P,K=O9VOSCW<S"P.!>3\W<3V$YO@Z.STW_A ?GF9")GX?GD
M&%YS=O3/_?K=S\' ^KW_Z?SBI\/3R^'@\BRXF!SA81@\>_DL@/OM\H?)?N7N
MYV!@Y8XG)X<_'YZ#*O+]Y'1R?G@"._#\_=DYW6<!?/>IU^[7NJR2^?J1+-Z?
M.9K+13P<P OBHH1WQ[,P.%95_2$X+@Z"X[Q(RN#G/+L*+A+XQR0.@UD.S2_B
M(IZN0<@*[&=0+53UZK%,R)^XO/1A G./33X]>)ED?\H(GQT,!Q>+.("UK>!?
M1XLDG@>3CW%45\EU')S-YPFL;)#/@Z-UE*HH3H/W"U4LX;_@%Y%*H>UW6700
M!BHXCE-UHXHXB/)BE1>J2O(L&&&S?TMGO]7Y:[15[%=X#ORMH"_&!X]YCA^_
M%#T'*;I$\7$6'B1*U=4"CHW_BV=!E<,'91T'+\.G3Y_B_X,2Y C> J*U*N)Y
M7!3PL[+*HP][87C0(WPAPC#/TS2_P;L"ECE/:Y2*,KB!ZR*8U>DZ4+-\5<&:
M3]=T]$QS5<Q0&F9)$4=57I!H5 VI:APG;_1#Q_HA]U3Y<^ZAO2!].F7RYQ\F
MYY-#\H*$PP&N_>$RAH[, I7-@O.XK!2*T!$I'W =53$* UQ(CLBTI0@N*SB<
MN*$03I_\.IE!S^9Y ;<8W'(EB5Y2>2=8I%9)I=+A@,ZHX$.6WV383N/P"N'V
MR\H$9@X$'UIIGG=A\)>G!T^?/@M6J@BN50I'X@HN6/HRI#-235/8/$6^#"J8
M'SPYZ=\)C"2#X17!,B] 3RMAUN+R40O 9RKB[4.M?9F*T)+,5J2_@>!D4:RE
MO?=R13EBT:$M!$WA)IJF2;D(K=1!1UCL0FHMJY=3U@*E7?AVBB(9I35N1F@S
M5M$B*&O\![4>ZN;GR4>G#3 :8C0N9!^N<K@/RE Z&<, N%L4D2J'@]9HFJ^A
M7ZML'?Q6PY+2$8#73!BDR1*V*]\Y,$?P>%4D$?]=H<V2PPK#PX]9NC[#_9-4
MVI1!.2O,?FCO*1"ZNL!-4Y%R:@_[:DW7 ^RLN%0)7!".$+-<>O(:^K(%(@5B
MBQ(&LU95(-WP?:KH.H"&E)9;Z5=C=S[JQ?HLQ/%\<G%V\J_)L3G/544+'9%E
M'1O+.F?+.M124";863RJ\#2[AN^>F$_E+,6#,(Z*N%+%6O\0=!70-5"(S5=A
MA\8S',!Q+8VLM<L&377G5L&O6??65TR\HI_ Y_,$=))J 5NKH6H=V],<YN6]
MNRW.::_0XR?V,(8M"FI3! K:C.ZKFZ1:4&]QOUWEOKE@QDW77<F'^=PZ&N!?
MCUJ>/HL=<WKV,VR42SS&WYZ=3\+@S21X=QF\_>D</PN\#168_=2A)+GNR$WZ
MD7L&-\Y?TGNFL5%28A8_,3@O^+&WL+.R:]P'J*F_-RU<8 MB>_)N<CJ$-PA]
M%L.=L$RRV%6LNJZ5X:!YKP3]UXJK$77H?*H4:[S<F\0/*)1R.3G_\8(@'7]R
MX'+O8[_+$5[$$=_!SPZ";W_Z[CB>)UE"N_K;+W_Z[B!X*V<4Z*.KO)0C(Y^'
M<BUJ+QJ>&R6:0FD:+-1UW/AZ&:L,_KW?X0]\A,:W>0@:8IK '>2X-(<#7.:2
M5+_W< F BH0W8BB*6TIZ(71:_U4MH+=7"]=S!%^C),6S1+&='D$7BCPE,QD4
M//DS9<\L?T8Q0?AFN807R@^& U+=E/2#?&IT#;&<HGI6E^P;P+L+O6)54<,'
MW-AY#7?G5T]?:F45-DD-MA=>8(=1M0\!/.P16@=]G,%Q%R7H.#V[R4!4%LG*
ML0<<V6X>;7*@@5I3H1H'L@:BA- >/DZ#KT>S,3Z^EY4'/<+FV/[KR9/@;1*G
MLU?!>W45OX8'?ZM1)88'7@=G*[HX7^$+1!!>!_]"-SI\'3QY(NC^;X_?_4OW
MCD?^I,I7,GKY8)I75;Y\%7R-GTW!'HT+\]F;% 8>/(-I!5,TF4$O+P\10'8T
M.3EY?WA\_.[T^__^XND7]/?%^\,C_;>\4EJ#*4O5JH2NZ?]Z#?;NK%K@V)_^
MM6LR+L]U&V1@1"K5ZP3]]Q<NC>?TQ'$7I%\KJL[KX+?.W.I9?1U<KE?P_L-"
M39/H=7"JEC'/_&F.\_G,?>A+_11^\^V7E\?XCW/\!\X._!NFO6,%ID6L/CR9
MQFCBOPI6M*KNJGS=L2H\'>_]192/]:9X[[_1[2@.@,7AD6V7QW\@.)='78*A
M7);#P;%:NS>%58)F:AW$'Z,8QHM_7JBJ+N"SD/^";NK_QA]"5T$_P5A*,(]A
M@ZH4-M$5_'.!FQQ^D&1T\_P$ZCG9\Z!\E=K3!M\/!W#M<"-3E7W RRD!K2:I
M)+8MC]-SJ-?@F'_)BP]-3QO%(WZKDX)UK%3=X$=LW5_EL/&S)<PY]$OQ30<&
M?I2"9;"_Z1[V"*U@KV'-RPZ]'L5'.1'N0D>XI_1$7RR;O+I+$."I?;P50=Y+
MS\,>H<7061<\14A='WS[E-SFM??\B&R);?=R-G$XYNOA@+YW43@DH4FUE\_/
M53X].$[;X$,Q#>X4VM,2MN&@)6T<4^,>"(YAZU;92^C#'J&#0EXND[+TQ=&]
M@WT-T/%-H=!,/D8+E5VAW.EF]I+QL$?H20:ZZINW6&!EPSEM_E:4^&6I7:."
M +30/HWULP@_.G7H"L5()-@5K/8;U&%I92W)JGPX8'M# GSF.SS?,$R@YF#F
MXTE7Q-0$G%QL8+"(SO:"^;!'V"V8P02L1Y PZ$V'QH=2Y8A*!XH:O?H5NNNG
M92)Q +%K;_(ZG070;E*E[(8%VQC]]8R9FQ.&*2+;=3A0;'33M<K]8^TPE!L5
ME,J0 !YY73F /#'(XVD5MM&S.A2>KP13<J.*0L$XK8F<4"0!360*?@P':-$[
M78D<O17W$#X9?XR+*"D)6TM_\OY@K&U>A*;UFZ2,]?C+G@F O18GU["9W4'O
M=]K#'J&STU!\2HK8'B[AI57W/5#62Q.\8EV5_- HBI3JLA>(ASW"3H$X]N.Q
MMX]9J7W,ZA&,L%,V+@BEWCHL0HK^H !<Q^DZ; #:W2O$IG_4*PZT2]MM5'_3
M'^.!*B4TCT]P,)ZOKKW0/>P1&J'3!BC<3U'/Y>28K,9<A1^CZ#S[QXNO_ PH
MC;(MZE3G7\17=2K^P561+^OT2H,ABY@ ''MA>M@C-,+T%H-D'&\:#BY!U2XY
MZO0';KEO]LB,1S%"(R/?'QZ^[_"4^5ZRJSC#D"IF]D88D$5/+EQ)H#^CK*P*
ML F3%1PP>ZEXV",T4O$#&<:>7-SRH'B^/R4>_@B-/)PDO]7)K!GEN;50O-P+
MQ<,?H1$*>&8X(!#,45X7OKOREH+Q][U:\2A&:&4CKY*(8\36CMY[5_8"H@7D
MK$B@BVB8O"/RH*;WS=J[,PG74TY,4I25G_&'$1'C.\'?-/TG8/"J8@;:J?F%
MY3RHT"B"7S,? ;:U4HC-!0NYV."2$3NZM]G( @UT]$50"^0^9FX&3&+$05#\
MKXFRV<OYPQZAA4]1"DUGG@]E\X 4U"JEL*X+=4$QE)2*$*04AD.1-_D)QX'K
MS/M$E64>)?+\KWF25<$U#+O&T#1%Z. W::*F29I4Z^$@RI<K$'C]4PY<FP\M
M5C48$4HV4& $1I0U5-93[#=Y+R5T-K8A/ JPK?76_ !CW,ORPQ[A+E# V][G
MC]\\E+'9A(;[,L(=LG&>[Q-O/F7BS?-]XLV]VJJ?TQENHT>[A9AL9.G%/K*T
MER(M16@:#0?'<9K F;IN66^WMNZCO77_"$9HY8-04\,!:1%_5$W4>5!!"8>/
M,:2S"&Y 9"%PN=Z<1U_L!>KAC] *5!U%,1BXQ7 P(0-S'\/>"X<6CLM"(2"Y
M+Y>8$H1->B]SSE'$6J6!/!K\J(H/,1%,YJLX(VZQJ:0H[\7D88^P+2:\V-WH
M>NUHMN1+]./2A9:7OC0U<'Y!FI3BH8.V\;^(J4X$C7UFY-0FOD2P_4H\E5[1
MQZ>JG*G?@B,FI!:I#-VOOD_SZ<9O+F($)/H_^.5B$OSXS\M V*A,\OH%$^,9
M&-E($N)+?=H2'; W+<+DN"_K\,!'Z.X*"H& .7@5=P'B,2$%2<W@K(1.H[2S
MB_CDY"@T',U&8DQ(A1S&54>*REYR'O0(#>7=<Z&\<SB_.:>"A.*]*@+1_I$(
M[Y(8;OM(+%F!\\DYE79%;$I9UTE3?3GK02MEW?@M6L3G9>Z^WG3IA6'Y'TF^
M'GV3Y15^6];37V%"B%Q4#E&=%84ON2F2JHH)[UW*;E"PM+\R%[7L#<Y"ZHU?
MCI 8'8OP;(!G"0^;@T5GOOGF(UX-C?%!,%$\(&;3;K[9T:N5D_D(OVPF/_(Y
M$$AB-_\L1MYVFIB_/#O Z?,[Y";6[.L%/9H1FN/A!1\/"86Y9\*'.6$^'U2(
M>.?/]/>HF\P29,6="N4._HAWG)KAJ# 8R>2#3.2[5+.XS_C_AOT&(O0:IS8U
MZ7\S+]=/'PEN'B4_L4*.(:>/V090 ,D[J% 914O+)\G\B:0KQK,G5?Z$U<0G
MHG--59F4-H62T01$!V130]Q"!^A#3;(QZV,SS4=$'A&8J"4>E[:?*JIJ@NNN
M5#+S>]U46#$+.69N!6IWSG@$IRV8\.W-' 2GN02 [:-FUMO/-R:OH\B4/69A
M$3BMU%V'EN)=9X3%:*UCLJS32F5Q7I<P(1C@3BDGEM-HDM(2D.]/G@<]0G/R
M?$4GS[]R J<S5;U50KKON"FF%H/J A_;#6QV;T";=4PGDF'RQ7)60OB-[U%H
M[!7UDM*507..*S(U4;W ]^@[WC*37.<(:\H,YW=7+O<N1TD@)XEH(IKJQZ/5
M9V7 <.M_SW!^[UTGZH8[YS=C23Z#+HY//COG=4$[WWG6/;+GVJKD\Z:$#8AI
MX(T+(+00E&DBK"Q8@$.*,R7_ITS%%SYG8&<G"-.J;&)+Z=CM!CHF&7+!(19?
MH$DOM#YFJ]"X:R0>YDI] ,TM3NAE4WG67=T@4L2EJXGH132P??AY4_73)[U]
M7,YQ?L-P$*G2>+>OX%Y"?!!J6"5G]3/S_<<UB[&-NL&'43RK\5S%CF"?=./P
MZED=R;O6YKU=8Q[9M'Y.,6SF]3/Z[J,\KW!A<KBP:(83&F4F=R^%^[")L21$
MYBD($+=#W:K+F(V _"/QKE1\Y9B)H<=@:::5XKT%/V[,IBT.Q+*@RA4*7JXI
M]/EXMY>J_P(&,<$GIC5S"C#NB<G[H/GA@">ZIRP!517CBG=.-3&DCH%.;"Q0
M U.&- V@\6!I#YIA7'HJG-?FSPHU5TCGLG/G82RD",C&%19"WH'Z;-E N,1K
MQ>QU/+DKV*<1I:S"9_N[\4&/T-R-+^EN=-(YG,(N!WA+/N99>/SK/%+CX> =
M:\?QM?8XP#&9VA5'@Z8T97C0R$(<*IR*]:J3=4UNP&MX(M/UB9+,_-G4/.#(
MY.I \N;XHU1,['?_X/V9.T6X#*Z[]PF+J6Z=E<.!)4^"HUAX8J@7*.3A+BZ7
MS>;BJDA(HZ';V]9U$5?Y<.":L88*BE^DRC*N.G4]F0"G8YYU ]<1AKL-7T "
M6I#1QRJWJH07>G<\-!T6*_P\ _4HU85:ES"VM(9;"0FGB,$6E( Z(^O-Z&D'
MP3MX$[$8X.OR**H+'C\/=3CX [+FS!$KEFCM58NZM+X!= TN<U'P^M91^P7-
M0B9966-9KB1F7\$*%7?VT8%YN91/22EHM#FOH053,LZL=X4JL2)_9TG]SA[D
M1L"!%!USWB&AQ*>,JLZU KU;V)4\GXV9;F</0$_A>?CYNGO9N.IC[_AHA^70
M!W>3=*R!4SU22)V24HKUN;1/[D;>JS0/>H2W*"[P8@]G_I1PYA=[./.]VAF/
M?^^/IJ#F_J15$/+IQBYKL'<IN7S\;BZZ9)0&:II?QPU_@M< %284QXQI#!T,
M5,=OY7C+_O0+?SAP;_Q@RX6?S/5%7\1+E60ZBM!2P?AK\AOQ[VV UKG7M9K3
M4)@:7ODJ2:5X%/90E5UZVY'#L>I&'>6FGI&_J:H+L\"F8GLN::3DVL]LU[@T
M(_G*9$IV'#Z^>^?APZ?>\+VAZQK<OH+3T,&I1CUI2.C'C6<ZM-&*3C=;UVH[
M-C\<C*"C]9)\DAZS&';;SR\UI&+0-;?!?=SU88]P%,&1^+81H*#X5I-_ Z$$
MO]M$<Z$:\9)WP92L0(4RAY;7=!W*N2;DZV$P2L9LVB&];)GT$+RSS]7+(IVN
M!80DYZ+CZR<GKME65.D W^Y% T8[D-6"Y5Q<J4SB"R&\K[C"G<=! JH>PU^@
M,1Q_E/;$H4X_C>=SJJP\'-#7)0$PVE&!.0-$3&PB7X(YFL8=$S%^C:\?)3!K
M*B@5_P:GG9-OJ2ATPK88?NBZ%DQ$PSO4NF.CAN+:BP309))O7Y5<V@^+X&"U
MOR55%JQP<.P",8YU=UF+X8"Z?).D:>@]Q#=3QQ,\QA'&6)*B8H2)2Y;-.?/2
MG02K^]"#>H8[AC0<=+W!)0(>TQV$P8<T5F45S),YR-LJ+B+*>7[Y]*]C/;/7
M'$E<Y3="&D ,L<5U<BVQ!&9-QC]$;),,.K"B ,>2QVZ"]5R2XSK6KU(()]TR
M,S!RUHQ[?[(_O!_T"$<S=MLZGD+RWL+6!/62B=]!6<&]+R<Y'/>LN)):PUJP
MNS>,YL2>/9=<@$#N=,B"8IN!*E4N0@Q&#0>,V\*-ZQSP&*::JZ00(#2#NSB:
MZNQ1<RW0U[-]6>K',D*XNH<#)Q\4 3F.G],K9(YG<A''(BG"-+%?_UN.T/Z?
MAW&?QCLZQ(.*>'-F;*PH]Q30"1)L1?)QTJTPDL8"A@KZ8+1-E^:ET$E&%F3F
M5CO(Z/XC-8NAMABL9R[D!2@.ZR>8Z /W:I)CG8,9:UHHD*,78TP"*JW>XKSP
M46_?STY W[" *L%!&TD%27D"B_Z$85[%'Y+0:3(SNIE(*V/#XVL)/%CPQ/B.
MA!3="7M!?42">B0G*3JH4"7+<A%:L!BG(#QRBW8**L4EFSJ9#0,C%EB@B:PX
M7N4@;/! M=#ZH,8D#0<&E+2W(1[T"-%=P"CJ95PM<@*<H5PH[6UQM?7;*'#!
MR+$6O)^K(J'SL,Q3/&JG:S AC &O7+>"XVI055TRVAS,WCF\03$D$\%KB.33
MGXT=<<^A1Q]B>@2M:C@@\2$$SU'LET/?"]UO;<@X>P#?1VY^V SHC (])@S@
MKB _R]&8)V).B9-T[EO;?<L^6]:"M'=>QEML.'!=6SK%P/&R&-=#.R.HZ7'
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M'>BES_''Z?RJ4%>%6IF2"^4"OH_)UM&(T0Y:%E\7'0[:N3*8^EOXF02.,!H
MITU,]K]@>5%(]0 Z*KVVWP,T'-S2!=0%\KMS-71_P]QE*N;7E(KI5L?Y:4])
M^;!'B-F7WII2=OO92KO@-6\34>&@(@$'ZC;ZI:E7]3XD!@)$0I*S!O.UFGE?
M @PG0+LYEW6YG<!6V\&6*(//= __XBY:'S<!A3E 22<8W2Y/2KR"@@7,)72W
M6I3!Z,7!\V_&+;"RX>=JT$JXS#;;2*''3>8H.[W!.;;AL4=ISA^9/<9F8K43
MNR3,I !WBX9BNO>B*:],R?0(VK1ODP-=516L'2P3SA$J6J0>'&99_#$X)#?
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MFLMM$*P?L4%"V$@9U)A4O2";T#,CK?VN5T&&)<L,YX!4#L'>QF57=6@X!BB
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M1G&:\H[:.Z<>_ B5ZWL4@A!BY1,P-V_]T@6N+I=U)K=BZ=1T)5P+J2KF/O#
M7*5S/;3QAL-!DX"CI_BA4V3(8.5L15ST8%%6!5I*1 DR5Q$!I> BILH:6HUF
M5C,X[ AMQ?%7?(CR6?*K#.8(-"UH,B/P0)3#T4LV4'&=8,DY:<9&7]W+1U6O
M'K/0_&D.)#,T"CY^^H$=K4'K@_-M.'@/2MP2_K.FZ"(\\BZ+[OBHNQ<C/H$;
M'X;[["G\DK QSYZ%P>$UZ'PO0]B"!\'?@_^GX+@/_HGZ0+1('N$<O $]O51@
M$US 0;0(@Y^35*T55S"-/]05*(./<-3_K&%=AX.3>@D*;QC\"'^MRT2%P<M_
M/'_Z]!$.^+"2^.FKX>!H@5&!R4>P#TD'/B-73_$(1SW!2^\57?)H9?U/)$?<
M 5SDGRQT?%^NI V F&=/]XB83XF(>?;TLX?$[%6N'0;V,^C_F*$<Y2M*#)&"
M>-:C95U)8HR,[UBW_N3+]#@6ZCB>3I-X./AGFL"O)N5OCU$=/D^( O!$W83!
M^X.CQSC$9T]?/L7"&1SN!/T'U?W@]&=XHH97!2]!^7MS#L/]6968IE>!/7L,
M4Q& 5OCBZT<X(9,G5D6:D9 ??  9_Y\"92%5-Y^%IO102_Y@MH3#%V*\/09"
M5!B'SVBU  ,G4A12ERJK'2D5Z-KF2,C:IO>9*KA3$_7P<7HFD--=K;R)G/H[
M(J?NWM/F9;18=]L?<9K!7^(WJRH5+33K2)?K+.CRG&'TT7.=^9ZS1K!;H%G>
M&G8X[LQ_>DD<$@QW@B!N'!S//!\?X=":WN*=_)*RZQ6M4#LG1R49$GBFP0H-
M+\)U&+86?P L$#8(V"$'#3'H6&,IQ\V<!92$;>.U4H!'%9B%R'GQFL&,4H-P
M&!C)E%!8:'*3;)_\WB2E(T18O=A.I-YDKN#TK##A._P);Q?RUEO'H!->OGKQ
M-%@=+ ^"$9X7O^3%A^ (XYTXE'$@= E<_9;**Q&R$,XIMUIR(]^-$TK_ U,0
M-&> V )ZI@"'AE -CL0*C$%YPX+F,-,'1X9D23M-E?.\9E6C?5-BBN7,:][R
M2+BQ1NR_9@K7!\1/!Q<'V\Z(MG<]E])1S'J!=!,I.>;C9%7IPTYHF0AAE2^]
M14I*-[AM*#P.,*B Y['A-[.@O3;0=4.>5C@<$'QJ>^*7G-!,W):9D :^5V*M
MN5/G.^G.9DY*0YQ[E>93.$HHNW2Z'@Z.+X],K-AR5\QB(MU3!29%NA-CRMZZ
M JO;X(S>KD9:N7TPK"B>U8R]L+WH;V%?8_#!1'>D%M'AE+!X<7!FLE\Y/#@Q
M*  ;]/<@($F&X([;[2@-9T,V#[J;ERN5%$)(:#K0><^:;&RE>XRW7HW%G#5?
M5,A4VFL#*HRQ'-A2:7854->H<K6&:95$,&VA;Z$![6[ UE?F'@WYJF=85$$7
M$-7$UHP##.:11&\X:P7@@Y-)*-G9/JC^H$<H13A.\I)TY1_K*N&TVZ;,.!O"
M ,_5-BZ1R-E%3O5!>4<8I/!:JE21QHR<A>NG*O(U?M>-DHHI#A*[-D'HT9P8
M'@/TP^%SQ!B"NXSX.-#.25.S0Y7MC=M9K@@)S8+R6>/O^*]VN]X( G< 7G.2
M'NU.AT:,]N_2,A\.>N8J\*<*.3; _E_S&+7ND<\-48M1WJ$1!J#-*]-&;6H_
M,KN%UV^JM2AGFV&>%RC?%LX<9_'VA\2#'J%P5'_/6C#HHB?J1O WL"5_JT&*
M--M6)+_0="5:O$*#\01[%2&446SRH!*,X\"-4CD7Y^8KF/(P^#2YHDX)%5$V
MTR]%;#P:E/RJ'D='S*]&EL94W1C3^*(RKX2/%1;3:W/T5$RF1P9SJMDPLSG<
MPK3SJ#W#F3)AC'X;?(-==-T*2%-5"FH5QI?"ZU+68*D81&N*_:E#XH?&W"(P
M-RL-:+))QVMI%LA2V48-8?BF"9P);[A"I&S54G0P2J+I,EP@;%)HS@BT\0\U
MW6RI>85S).?@7 ;\+S<[!MT<JQ3.._8[89H#UEMRJMT2K#0VN@OET3%9RCQ&
MVHV4;+<*]+>$\^[DAT<"//XY29?L1 [-RC?IT<SG1]24RXZV<95A89QEEG26
M! [[ZSSB [2>+I-*TS0&5$&WQ$GZ%<S-<I9$KD[9Z(6Y2S I<.;D_TAQJ%5=
M.91-^FJS643TG69E-PE%CJAT$7)(5=FH)O>8UJ6)S+L]NAL%0RF%=Y5DG$N?
M,*$<0HY-)9L$*_Q&VG]D13_4^57)4GP)QIU@/8(XC;\2J)RGL3EY7.[%G[U0
M6-[;WU!* VCW!+]G%8 0TEF"NPO^73NL:K:GNV_W]DR!L4Y39<9D7)',)A61
M6T^.N5A2UO3G3$.%#\B!IRF9^F<5M[VX0@(=V.1#:SA >QO.NZ2LR/Q&,X#/
MAGA&SY#;S_A%#-"?^,P\S4-_-;:51X4KNQ*Q94<:JG&<$V ]$"5!VY-J-^8B
M1\!82'CX,H62S&2#M%=Y/A.%$<\<6M;N^29Q95RZ'.FG.3%#.@R38AHUO9O0
M?<*+ZA7!*FLF-9!F!!?,O$Q^Q9X>N)PS=/A8]GV\Y6R:$X9\_H"TF7TIVV5>
MIW"553IYPKPV:+V5*.1L0,",I<)\"?SYKS5SBQ&57>,6@WT%QC:ZONM*E&LF
M@N/4S:W7D)QV[EU&B4/-(XILE)[$#"\50M\=\$WW+D'O/U^L?J9Y)XD8.68]
M%QRE^(DS*KZ6[<8$ZCI]I?.U3O9GLIS611DWZ-ZYC;EP&*H*+M L7FM^TN%@
M'GN<K!&8$/PW9CEE&"2"(ZTN"GMK)G"^P?:X$H<%]!?>8>4).E<2$,TY3[NZ
MOE?X'_0(;P-.>[8'IWU2<-JSSQZ<=K_VQN/?_4+B]#,J!X7-LR%EH;?6D$./
MB$PFDI7>0\RRW;N.>CVJW6S#T9T_C1WCGD-E2G=*WB0%1LS;M6:N7V]^Z'=P
MM[#:<-#40I0S)[8=@5EPRJ7.G^W0S]Q90QTW*T'5EKQ>T*.0<7.V8))U37&#
M>=5")+Q-1_+K\>11I,K&],I\(B4E>DO,5%(PK$#;DU1HT=5]WA#N]MB0&CO%
M+25*O7U G&,,(PJ\IOF3W89HGH*.R AO(ZM+V&@^UF2OMSSH$0H]V45,6?*@
M9R.!O0Y6W/HD2E ])K=E&"0I6S$Y5GH56X#";8RLP;PCI_KT)FO 3[\V-J_$
MW9K]I#XXMI<<!+;.4Y044;UDVN;0DFT0&1=T+46;DM\%YZC?#I*S5&YU)W(L
M..V5-'&F3>+$J;.9S:HG]V-<.L6=%.>*B^UKOI_5G@?J.LE3J@+6H.T RU(<
MND2?4H(1&;:H/62INMNV+"XY)NE'Y!6"CJ>8,28XKM]J6$CRWR[5QV19+]MM
M6M.76VW8W(]Y#SW^4^)*$HD17_5&P]N.U;K!9,><!FN_>)D3X.\"M-6Q13SI
M^B'H5/#>(S@7:=N)92S5S"#?"/TEO.BX&=P&]O+WH$>X8/G[(2:0FF2RH[*X
MD$_:3D7T1,^9G(3]SWC99 B!G>7-U!/FZMHMC&8YGD0C;#HM\T+SM#AT)H[_
M2]RACWFY'K] )J(V5:JJ2TMCT $#\;2I#= %&Y73#9&35XIC=H' ^5 T!'M:
M2:+Z!CJ<QYTS#&TS C[4F5#+V^XTJR^Y4@Z:0(9L=R3KO!6X7L$%PY3?ZL$S
MZVAC9)^?H&_Q_CW?>_\^J??O^6?O_;M3O_8;T_DWCYJ)' ;Z[G0X^/G=Y>GD
MXB+X^8?)^>3LK>5 )KT53[]8RM4*KF[6UAGH@W__^]^LT\[Q/_%_P?.GSU]^
M?L>A<Q*Y)T_S9+KU+'@'4\_@S#G9/MF^H$WHG%^[O[GCI/M";VE[NNW:WB=<
M #CN;+>.SG#^3__[B^>WGNP[9>'YY>CD$!:?._;^A\/S'^'/GR[?'1V>7(3!
MNU,G+U<?UY_92NV[M;U;>[GX4[OU9OUJ8Y\:ZNC45T>YP?_\5-XGH3$7V$O2
M=.^C -DNWFD/26._VPY^=;<]/ ;#^0/WZK@X"([!=BZ#G['"\04Z%B?Q?16J
M>RI(=]FM2^3>O1OQN5.U!CG'N"<MXK&.4':W (E5>J\,P-_CXGBQ=W%\4A?'
MB[V+XT%YJWGE[Y3N\/1T\K_#P>$#(\NZY[-Z>@9FZ&0X.'L+UO+IOR;G%^_.
M3A_6$+9,>Z>WZ#\N*Y>(+/ <; R\C],XXH0-S;-O(Q9=P8<VT;Z3B]3X3B<A
MA5QDG1LFZ$G$A2:D&KNI7FVK3^A'*>XCC)M!)Z>P9- 9F+ZNFRSY*)S!;@EF
M^C$P-F2$)SVT?L[E1+"A$[?N_>^8F/YPIYDC!A3.+1\(@K^J. NF<9K?' 1'
M7-F)(DP\PKIT0K'024(GFIH"LWA.L5H.,9$[E3!Q-M-M&:N, KLN48H4M>KM
M[QT[5^_[<7C')@\+G>5C?VA,C/>H?Z>:^0BV8V_(EP&Y)G"\G^Y/.]UG-QE%
MYX5@:B_G?^[$'Q+(>3_K=Y=K=$'77@WFVW#P[_[_W=T [M],D&6\<?0T 7>\
MD/=O'M@IMFTB[GXF/K<MMU-ZWU>O@S,J^E>^"DZP&N/>!7;W+K"O?J\+[,$Z
MI+Y\<W;\"_J&O_SA\L>3[_X_4$L#!!0    ( !J(U%J& <0>R@T  (1!   *
M    97@Y.2TQ+FAT;>U<;6_;.!+^;L#_@1?L%5W =IQTWYJDP3F.T^;J)CXG
MV<5^.M 2;7,CBRHIQ?7^^GMF*,ER[*2[V#;78EV@M2.1P^&\/IQA<_3F^EW_
MN%X[>M/KG.)3T)^CZ_/K?N_X:-=_XNUN_OKHY/+T5W%U_6N_]VIG;.+T0.RU
MDU1<ZYERXD+-Q=#,9-SP#QKB2ED]WL%$3!W\V7F'8B;M1,<' D-WCH_.+B^N
MJS2:8SG3T>+@8U1XK-._*[_HSO&S>.22PZ-=(HA=#CX%?X<B51_2IHST! ^L
MGDP_*<M')\>]#U,]TFF]]O)E:^]H]^3XJ]K YY#Y)Q7P^;O7XFK8?;6C/KQ\
MV=S[;[N]U_HMF>R(3O_ZU<[.)Y;VER[:56L(5)PJ^XGMN?MKM]_I]OKUVN!-
M9_@.7V^NS[N=_I7H7%Q<WEQT>U?BFQ?BW7F_?WYY(0;#\Y\[U[VCDR'V-Z"9
M[WI@YO+LK#<\OWB-+Z)[>?%S;WA]?M+O87@/+X:]4[![V7W[N?WETTOH2W>8
MSV]UOV4NU>/%)S:[MS>=?J=>Z]^\&]P,&^+?6:S$?KN!O_O?"S*39W$HW?10
M=!=!) ,5B<%4VAF^9:D.9 3JYW'0$L^?1>'[S!P6PYY9_O%;\?RB<W7:^<^!
M@(%W&Z+ZT^#;AI!BI$VR0K)>"\PLD?%"I%.9BE#=J<@D3N@X-G<RU7=*!#(.
ME!4S%>I QZHA4A/*A9 8D>%-Z&?J5$RE$VR+>*;CU& ]IX+,ZE1#4DEF XQ0
M0DZL4C,,A(PL)BOA9*3J-3,&$2<"$]\IF^I1I%B6F'HF!E:-E27"5ZD);DL)
MW'M>"D+'6#RQ&EM0(B$A\8+@"5M));T. DS3*?-ZIUQJK!,+K:)0QY-Z;6*-
M \_6!$J%3H"W;UZTV@*JC[2)Q4B!=P5QA5F08@(&@ _ZHCXD*G;*M: JVDNL
M,  SYCJ=\F:+D8VEEK5S&<G1""6#:<E/HUXC";((.J UFX&.X_V7PIQ+:Z7?
M6?GL16/_QW:CW6X+!UTKYIY6[GI-/[..A.16*#9$(JVXDU&FQ#?M%C*02*!T
M)E"OE0;G9ZS*&LJ7,?:M;*"Q.J0>*!98N_5]A4JCV,K)7]@*6TF5B\=6_Z&]
M7!V#PH*![E^4I5^_7OLX S]5&'@>F"@B8X"'+1JLD%RJO_AU72'1EKC&R^(I
M693&_#'YXD))F.G8FAD3"&'>WG%@0>2F?FIIC$%D' P+6UV)-:VO+'1^E?$>
MBJC78I6N!)%J ""[B"*$$I&1DB@8SHV]9;W)1*<R8J.=J%A9? ^,38SE>);A
M&X>8$YFKEP-GAD (\S6P.<E!2<(J9@F%'X=84H8;"E$!)J13#5O2,0R'XU%J
M)@H,6A^KELFE"!=(3;36%%PU,"8B2JD"B[PZO;59/$=JX. /ZC84[S-ID1&V
M9O=43/>00>HU'W)@</<3IUY-L*RI%ZW]']?"FQ\//4\U4M)],C-H.38I&6].
M#J_(;$R6KED.V*%)4Q.%L 29P"&0:#@T7D@7RO<BTHX-UF81F37%,#^Z=)K[
M#+#Y8748O$XCGSR1P8!I=$(^0AD>H";4=SJ$B3IP'%*HC!_8J'AN: 9<IKG<
MT$@Z[0 FQNR(\ZG"[ S26%*5# *P77#6$IT0@ +>ALWI&/X\DYSZK9I(2[!B
M=2=% BFVHN,@RD+&(P OW=R;API>GY+?G8&@^*GY%BX;Y=)F@C>MJQ;,H01:
MQ&OO ])7/.&</T-R !M;[WNJH%\!O2-%:L_Q'4,0F#4IF!2WCD^G$CG>^Y5B
MNX%?,)S.8G(=FE11="=(R8SW7KYX 6P/Q8,&V<_SE+C(P<7J^ )B- 2R#3F(
M2\%!&>(KG$=RCGVRW8.#35NP*M*$.<@VAVJ21=[:KPJ77:Y<KV%I[]:5%2HQ
MA%,B93*[(J";F/'Y%?$(9M2'0$'=2'\$=ABG$?+"7$95N;RL9X,WQD+EG5+8
MB7#@&=%) V#-I\4EDEJ9:]7[#)"+9KOUW8AR,_>#$DFGA&TLMF)C(<@%:;00
MG!C5\LA1KQ514U;L0"+IIPVO]3E65;8A1M;<P@:PFU#AO&2W_OPD_JRAH@0)
MPY&]*SH2>-A&EHM,@173+*7CA=<U*=@IO">K(V-&0DJ]59GQRJA1MMB4V1I+
M"P*)]52ZFIUC8W-^"+@I\B7V:AC(0YD3,\H5\BS)OD(O?H.).QSSF5^\],F?
M<Q[SW5C9$=*I]4O-30:O)20;(VZ,LZ@2L.[%%"^&A2>Z<>&M83]--:H3WFF'
M$/2YZY-;D7NF.S:HUUY;DR6BGP(M.F7O**4B<1>G,#KR>:U0A%C6AQ[ "UM/
M>0*FAYJ+/8-6MZJR")B>SN19C&A?5=96)T\4O48 396BQL9*^3:T/0W3A1;J
M-4W1+(AT3%IH(K]/5&.]ZR"*ID/>;^!#TH,=!T<'<5_G"@A:!5B-VA# ,"ZP
M.LF/W+8\@]1KA,1G.C4XO]/JD9DL/&1_>!+5Z296SJA$0M$6 $DWB08X+M\E
MH&0<5T^HG3+HO]T#X]P<-T!'"-0)B/&Y@7!]O38R.*43: I%FLVHQT"L3=5,
MIL05"V/&BJ'X3\6/M;H;'TO49,&,$6[4P%J2BA#*.CW65*A8$_ H<R2Y7'1<
M^, !0R<XL\4,#2%L>$UH,ZHVQJ&F4C*8"T/"NMS1B .6VRK#5-R#5EAB8/:,
M8.[&JD<#LF*XC'2F4S&?SUM!$2*A_6V8?(HP>8_=?S2;XHQ:7 =B ,<\Q,3W
MF8*O88)H-O,[.$>GYS\7RWMNFZE)<H[S!S#KU,P.Q _T;&0LP'[Y[ 1*OA5[
M$ 7;/=BX[E!;O-OK]P>=T]/SB]>O=MH[_//5H-,M?LZ7S*E1MT0F#JP5WP[A
M4F$ZI<VU_[EIM]?#@@;7-RD Y;(%_ZO"CM289YP6,RJDE\J^/J6+2$/ZAW:
M3XAF@Y1&5LG;IN\)'B "D&BKDOMA@^0\RX-50>>/B_4'JRM6U+=+^O,J^_+-
M\.OTG9-C!+>YM&$S,N:6F\)714UIBRO^?^67O$SNJ&%65<^RXN=S;WYHFBD9
M^P8]E? XT>__V-E<U=M436T4T^JU_;W>AGEEJ7U)X+N5<BSE3YXCQTJ\D18!
MCO $Y47DT(+BS948Y.>["O$^/B8>G@PIO,RXE.J7>?F]K\\B@!.:<H[R-^#1
M4@X-8;B?EX+!JG@P'8(%8F&H,)8!E[+H6H3*:Z^:[CY4I,[@"<(?WW>)"E7
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MO_+E_2UXM .Z*R/U_'V,@%G:B!42]KA:J-0C3!31R\$]*C'5>5_=%N:& P<
MB[UB9DN8!=-2GR$0*E&FF^? "OIR!E8Y;H ,B 20'>P,2A$(W)WE&SH!/'Q#
M"E!4H6<L(6O<D4*(GT)%A(.'M(\7$(!PN61H&>*&F!%$>3BP*> TQ-UN0* U
M_D8\&-$Q'_DCQ!YWS#!04^23E\W@;U.R1BE"0+Y$JDK<D# :@><"$QM@R?M@
M:<F W^(+UN]'3#":2/QL>]JHX>)"$R25;UNFHIT;N4@AH'0F26E!/ WP[+'
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MG=X>/;LH?FE[F\?O:VW[IG+8^/CVK5R)8L_2)_CWT!L9N_\/4$L! A0#%
M  @ &HC46FG.E'2_ P  O@X  !$              ( !     &-Y8V,M,C R
M-3 V,C N>'-D4$L! A0#%     @ &HC46@NRKMSS"   96@  !4
M     ( ![@,  &-Y8V,M,C R-3 V,C!?9&5F+GAM;%!+ 0(4 Q0    ( !J(
MU%KVS3N4X@L  -&/   5              "  10-  !C>6-C+3(P,C4P-C(P
M7VQA8BYX;6Q02P$"% ,4    "  :B-1:+>6\M3X(  #_8@  %0
M    @ $I&0  8WEC8RTR,#(U,#8R,%]P<F4N>&UL4$L! A0#%     @ &HC4
M6J@EHNGOB   7Y8#  H              ( !FB$  &5X,3 M,2YH=&U02P$"
M% ,4    "  :B-1:Z05J;PA"  #;P0$ "@              @ &QJ@  97@Q
M,"TR+FAT;5!+ 0(4 Q0    ( !J(U%IBT0^:!D(  /FV 0 *
M  "  >'L  !E>#$P+3,N:'1M4$L! A0#%     @ &HC46K90$4+Y00  Z<L!
M  H              ( !#R\! &5X,3 M-"YH=&U02P$"% ,4    "  :B-1:
M<EI[QQ!'  "TX $ "0              @ $P<0$ 97@S+3$N:'1M4$L! A0#
M%     @ &HC46H8!Q![*#0  A$$   H              ( !9[@! &5X.3DM
M,2YH=&U02P$"% ,4    "  :B-1:U$<HF1,A  !7YP  "P
G@ %9Q@$ 9F]R;3@M:RYH=&U02P4&      L "P"0 @  E><!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:CYCC="http://cyclacel.com/20250620"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cycc-20250620.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
        </entity>
        <period>
            <startDate>2025-06-20</startDate>
            <endDate>2025-06-20</endDate>
        </period>
    </context>
    <context id="From2025-06-202025-06-20_custom_CommonStockParValue0.001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCC:CommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-20</startDate>
            <endDate>2025-06-20</endDate>
        </period>
    </context>
    <context id="From2025-06-202025-06-20_custom_PreferredStock0.001ParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCC:PreferredStock0.001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-20</startDate>
            <endDate>2025-06-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-20" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2025-06-20" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-20" id="Fact000005">0001130166</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-20" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-20" id="Fact000011">2025-06-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-20" id="Fact000012">CYCLACEL PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-20" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-20" id="Fact000014">0-50626</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-20" id="Fact000015">91-1707622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-20" id="Fact000016">Level 10, Tower 11, Avenue 5, The Horizon</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-06-20" id="Fact000017">Bangsar South City</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="AsOf2025-06-20" id="Fact000018">No. 8, Jalan Kerinchi</dei:EntityAddressAddressLine3>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-20" id="Fact000019">59200</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-20" id="Fact000020">Kuala Lumpur</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="AsOf2025-06-20" id="Fact000021">MY</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="AsOf2025-06-20" id="Fact000022">(908)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-20" id="Fact000023">517-7330</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-20" id="Fact000024">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-20" id="Fact000025">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-20" id="Fact000026">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-20" id="Fact000027">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-06-202025-06-20_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000028">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-06-202025-06-20_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000029">CYCC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-06-202025-06-20_custom_CommonStockParValue0.001PerShareMember"
      id="Fact000030">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-06-202025-06-20_custom_PreferredStock0.001ParValueMember"
      id="Fact000031">Preferred     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-06-202025-06-20_custom_PreferredStock0.001ParValueMember"
      id="Fact000032">CYCCP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-06-202025-06-20_custom_PreferredStock0.001ParValueMember"
      id="Fact000033">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-20" id="Fact000034">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
